[[1, "response to interferon-gamma (GO:0034341)", 1.3336127778476142e-10, 29.579950289975145, 672.5877056730069, ["IFITM1", "GCH1", "CCL20", "KYNU", "CCL5", "CCL2", "GBP2", "CX3CL1", "TLR2"], 1.19625066172931e-07, 0, 0], [2, "cytokine-mediated signaling pathway (GO:0019221)", 5.636790875266018e-10, 7.581696779261587, 161.46387855314202, ["IFITM1", "CCL20", "TNFRSF9", "EBI3", "CXCL1", "CX3CL1", "CXCL5", "IFIT3", "IFIT2", "ICAM1", "IL1A", "MT2A", "CCL5", "IRF7", "SAA1", "CCL2", "GBP2", "XAF1"], 2.528100707556809e-07, 0, 0], [3, "cellular response to interferon-gamma (GO:0071346)", 5.5515596247830145e-09, 18.71281512605042, 355.7154008147536, ["MT2A", "CCL20", "CCL5", "IRF7", "CCL2", "GBP2", "CX3CL1", "TLR2", "ICAM1"], 1.6599163278101214e-06, 0, 0], [4, "neutrophil chemotaxis (GO:0030593)", 3.8032671024636885e-08, 25.34227330779055, 432.9681850211753, ["CCL20", "CCL5", "SAA1", "CCL2", "CXCL1", "CX3CL1", "CXCL5"], 8.528826477274822e-06, 0, 0], [5, "granulocyte chemotaxis (GO:0071621)", 5.110585966256342e-08, 24.186694531522118, 406.0792831655491, ["CCL20", "CCL5", "SAA1", "CCL2", "CXCL1", "CX3CL1", "CXCL5"], 9.168391223463877e-06, 0, 0], [6, "neutrophil migration (GO:1990266)", 7.428834128840538e-08, 22.8, 374.26910930342575, ["CCL20", "CCL5", "SAA1", "CCL2", "CXCL1", "CX3CL1", "CXCL5"], 1.1106107022616604e-05, 0, 0], [7, "inflammatory response (GO:0006954)", 1.2935502184673125e-07, 10.652597402597403, 168.95770600871288, ["IL1A", "ADORA2A", "CCL20", "CCL5", "C3AR1", "CCL2", "CXCL1", "CX3CL1", "CXCL5", "TLR2"], 1.6575922085216846e-05, 0, 0], [8, "chemokine-mediated signaling pathway (GO:0070098)", 2.4639325912614405e-07, 27.076363636363638, 412.0030728264414, ["CCL20", "CCL5", "CCL2", "CXCL1", "CX3CL1", "CXCL5"], 2.76268441795189e-05, 0, 0], [9, "cellular response to chemokine (GO:1990869)", 3.7423195029081406e-07, 25.065656565656564, 370.93136256316365, ["CCL20", "CCL5", "CCL2", "CXCL1", "CX3CL1", "CXCL5"], 3.598144872904596e-05, 0, 0], [10, "cellular response to cytokine stimulus (GO:0071345)", 4.011309780272682e-07, 6.651425412619442, 97.96869747013143, ["CCL20", "EBI3", "CXCL1", "CX3CL1", "ICAM1", "IL1A", "MT2A", "IFI16", "CCL5", "SAA1", "CCL2", "GBP2", "TLR2"], 3.598144872904596e-05, 0, 0], [11, "cellular response to type I interferon (GO:0071357)", 6.059030542472905e-07, 22.93567026194145, 328.3595746799784, ["IFITM1", "IRF7", "GBP2", "XAF1", "IFIT3", "IFIT2"], 4.529125330498496e-05, 0, 0], [12, "type I interferon signaling pathway (GO:0060337)", 6.059030542472905e-07, 22.93567026194145, 328.3595746799784, ["IFITM1", "IRF7", "GBP2", "XAF1", "IFIT3", "IFIT2"], 4.529125330498496e-05, 0, 0], [13, "lymphocyte migration (GO:0072676)", 1.1899180012658313e-06, 31.895666131621187, 435.108753482637, ["CCL20", "CCL5", "SAA1", "CCL2", "CX3CL1"], 8.210434208734237e-05, 0, 0], [14, "lymphocyte chemotaxis (GO:0048247)", 1.9350016361623484e-06, 28.61855373091328, 376.48859003326345, ["CCL20", "CCL5", "SAA1", "CCL2", "CX3CL1"], 0.0001239783191169733, 0, 0], [15, "response to tumor necrosis factor (GO:0034612)", 1.326158068345706e-05, 12.98208041958042, 145.79706350896578, ["GCH1", "CCL20", "CCL5", "CCL2", "GBP2", "CX3CL1"], 0.0007930425248707322, 0, 0], [16, "macrophage chemotaxis (GO:0048246)", 2.1449603162814258e-05, 72.88278388278388, 783.4756718388893, ["CCL5", "SAA1", "CCL2"], 0.0012025183773152744, 0, 0], [17, "defense response to symbiont (GO:0140546)", 2.6229810336523823e-05, 11.433744221879815, 120.61015431298368, ["IFITM1", "IFI16", "IRF7", "IFIT3", "TLR2", "IFIT2"], 0.0013840082277565807, 0, 0], [18, "defense response to virus (GO:0051607)", 3.893448278058283e-05, 10.618647100930566, 107.81781645206512, ["IFITM1", "IFI16", "IRF7", "IFIT3", "TLR2", "IFIT2"], 0.001940235058565711, 0, 0], [19, "macrophage migration (GO:1905517)", 4.3910167237293897e-05, 54.65384615384615, 548.3619687932247, ["CCL5", "SAA1", "CCL2"], 0.002003222976204444, 0, 0], [20, "monocyte chemotaxis (GO:0002548)", 4.466494930221725e-05, 23.237426900584797, 232.7535385732318, ["CCL20", "CCL5", "CCL2", "CX3CL1"], 0.002003222976204444, 0, 0], [21, "response to interleukin-1 (GO:0070555)", 5.3119781397321337e-05, 13.75017339436815, 135.3424227749377, ["CCL20", "CCL5", "CCL2", "GBP2", "CX3CL1"], 0.002012993357482607, 0, 0], [22, "regulation of inflammatory response (GO:0050727)", 5.328694935383352e-05, 7.967943164096344, 78.40311940886603, ["CCL5", "CASP4", "SAA1", "NMI", "GPSM3", "CX3CL1", "TLR2"], 0.002012993357482607, 0, 0], [23, "eosinophil chemotaxis (GO:0048245)", 5.3859354046357384e-05, 50.447168216398985, 495.85199971948134, ["CCL5", "CCL2", "CX3CL1"], 0.002012993357482607, 0, 0], [24, "eosinophil migration (GO:0072677)", 5.3859354046357384e-05, 50.447168216398985, 495.85199971948134, ["CCL5", "CCL2", "CX3CL1"], 0.002012993357482607, 0, 0], [25, "innate immune response (GO:0045087)", 8.906021084227534e-05, 6.205347255181143, 57.87229648205343, ["IFITM1", "GCH1", "KYNU", "IRF7", "SAA1", "PI3", "CFB", "TLR2"], 0.003149628203408871, 0, 0], [26, "cellular response to interleukin-1 (GO:0071347)", 9.129357111330061e-05, 9.040726052471019, 84.0916822241917, ["IL1A", "CCL20", "CCL5", "CCL2", "GBP2", "CX3CL1"], 0.003149628203408871, 0, 0], [27, "positive regulation of defense response (GO:0031349)", 9.909178599690052e-05, 11.968708469252144, 110.34507693139864, ["CCL5", "NMI", "GPSM3", "CX3CL1", "TLR2"], 0.0032920493347859173, 0, 0], [28, "negative regulation of viral genome replication (GO:0045071)", 0.00012087841468374806, 17.64977777777778, 159.21379790798704, ["PARP10", "IFITM1", "IFI16", "CCL5"], 0.0038724263561186432, 0, 0], [29, "NAD biosynthetic process (GO:0009435)", 0.00012575499061511243, 36.42490842490842, 327.13847921682, ["PARP10", "NMNAT1", "KYNU"], 0.003889731951095029, 0, 0], [30, "cellular response to oxygen-containing compound (GO:1901701)", 0.00014160157255468619, 5.7854558877814695, 51.27356387602232, ["HCN4", "IL1A", "JUN", "CCL2", "CXCL1", "CXCL5", "TLR2", "SSH1"], 0.004233887019385117, 0, 0], [31, "positive regulation of ERK1 and ERK2 cascade (GO:0070374)", 0.00016149031955014893, 8.107886089813801, 70.7904833650918, ["BMPER", "CCL20", "CCL5", "CCL2", "CX3CL1", "ICAM1"], 0.0046728005366607605, 0, 0], [32, "cellular response to molecule of bacterial origin (GO:0071219)", 0.0002103275632626544, 10.110316649642492, 85.60247808367819, ["IL1A", "CCL2", "CXCL1", "CXCL5", "TLR2"], 0.005895744507706281, 0, 0], [33, "cellular response to lipopolysaccharide (GO:0071222)", 0.0002564023143961114, 9.66829506595017, 79.94483864313798, ["IL1A", "CCL5", "CCL2", "CXCL1", "CXCL5"], 0.006969481091312482, 0, 0], [34, "regulation of viral genome replication (GO:0045069)", 0.0002796301234248833, 13.998589065255732, 114.53705509322698, ["PARP10", "IFITM1", "IFI16", "CCL5"], 0.007377300609180009, 0, 0], [35, "interferon-gamma-mediated signaling pathway (GO:0060333)", 0.00029604498442361237, 13.779166666666667, 111.95571732737321, ["MT2A", "IRF7", "GBP2", "ICAM1"], 0.007497481250306519, 0, 0], [36, "response to interferon-beta (GO:0035456)", 0.0003024604907066452, 26.216703296703297, 212.44862549968624, ["IFITM1", "IFI16", "XAF1"], 0.007497481250306519, 0, 0], [37, "cellular response to tumor necrosis factor (GO:0071356)", 0.00030926065358009055, 7.151112185686654, 57.79046953270837, ["CCL20", "CCL5", "TNFRSF9", "CCL2", "GBP2", "CX3CL1"], 0.007497481250306519, 0, 0], [38, "ISG15-protein conjugation (GO:0032020)", 0.0003238299215620844, 108.16304347826087, 869.1216502274136, ["HERC5", "UBE2L6"], 0.007611417699485233, 0, 0], [39, "negative regulation of viral process (GO:0048525)", 0.00033093120432544493, 13.36026936026936, 107.06385516144874, ["PARP10", "IFITM1", "IFI16", "CCL5"], 0.007611417699485233, 0, 0], [40, "nicotinamide nucleotide biosynthetic process (GO:0019359)", 0.00045197447980601367, 86.52608695652174, 666.4139574236976, ["NMNAT1", "KYNU"], 0.009888319716731568, 0, 0], [41, "regulation of natural killer cell chemotaxis (GO:2000501)", 0.00045197447980601367, 86.52608695652174, 666.4139574236976, ["CCL5", "CCL2"], 0.009888319716731568, 0, 0], [42, "positive regulation of response to external stimulus (GO:0032103)", 0.0005043814917905875, 8.28945161831293, 62.934989291251924, ["CCL5", "NMI", "GPSM3", "CX3CL1", "TLR2"], 0.010772147574670404, 0, 0], [43, "regulation of type I interferon production (GO:0032479)", 0.0008233616499937331, 10.36392156862745, 73.60576308940142, ["HERC5", "IFI16", "IRF7", "UBE2L6"], 0.016785350001008604, 0, 0], [44, "positive regulation of inflammatory response (GO:0050729)", 0.0008233616499937331, 10.36392156862745, 73.60576308940142, ["NMI", "CX3CL1", "GPSM3", "TLR2"], 0.016785350001008604, 0, 0], [45, "regulation of ERK1 and ERK2 cascade (GO:0070372)", 0.0009072374228325681, 5.781935736677116, 40.50307488839688, ["BMPER", "CCL20", "CCL5", "CCL2", "CX3CL1", "ICAM1"], 0.01806215414944584, 0, 0], [46, "response to lipopolysaccharide (GO:0032496)", 0.000926264315356197, 7.205603385378666, 50.326462679205676, ["IL1A", "GCH1", "CCL2", "CXCL1", "CXCL5"], 0.01806215414944584, 0, 0], [47, "positive regulation of cytokine production (GO:0001819)", 0.001022872750390349, 4.802565180824222, 33.06633453399843, ["IL1A", "CCBE1", "IFI16", "EBI3", "IRF7", "SAA1", "TLR2"], 0.019521635257449852, 0, 0], [48, "PERK-mediated unfolded protein response (GO:0036499)", 0.0011693273243550079, 48.06038647342995, 324.47136714038277, ["IGFBP1", "CCL2"], 0.021405849182580452, 0, 0], [49, "positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770)", 0.0011693273243550079, 48.06038647342995, 324.47136714038277, ["CCL2", "TLR2"], 0.021405849182580452, 0, 0], [50, "positive regulation of smooth muscle cell proliferation (GO:0048661)", 0.0013183990059261002, 15.228469205213392, 100.98511362094811, ["JUN", "CCL5", "CX3CL1"], 0.023652078166314237, 0, 0], [51, "negative regulation by host of viral transcription (GO:0043922)", 0.001648199307369968, 39.31818181818182, 251.95373669213362, ["JUN", "CCL5"], 0.028988917229624732, 0, 0], [52, "blood circulation (GO:0008015)", 0.0017782858455118796, 13.638736263736265, 86.36191536485507, ["HCN4", "ADORA2A", "C3AR1"], 0.030675430835079922, 0, 0], [53, "positive regulation of MAPK cascade (GO:0043410)", 0.0018619897184532742, 4.996099050203528, 31.40602631154181, ["BMPER", "CCL20", "CCL5", "CCL2", "CX3CL1", "ICAM1"], 0.03126495153494019, 0, 0], [54, "regulation of nitric-oxide synthase biosynthetic process (GO:0051769)", 0.0019170260138480608, 36.039855072463766, 225.50066121848297, ["CCL2", "TLR2"], 0.03126495153494019, 0, 0], [55, "positive regulation of lymphocyte migration (GO:2000403)", 0.0019170260138480608, 36.039855072463766, 225.50066121848297, ["CCL20", "CCL5"], 0.03126495153494019, 0, 0], [56, "regulation of lymphocyte activation (GO:0051249)", 0.0022051992386726655, 33.26588628762542, 203.48534452549944, ["THEMIS2", "CCL5"], 0.034104546846368634, 0, 0], [57, "heterocycle biosynthetic process (GO:0018130)", 0.0022051992386726655, 33.26588628762542, 203.48534452549944, ["GCH1", "MOCOS"], 0.034104546846368634, 0, 0], [58, "integrated stress response signaling (GO:0140467)", 0.0022051992386726655, 33.26588628762542, 203.48534452549944, ["IGFBP1", "CCL2"], 0.034104546846368634, 0, 0], [59, "response to organic cyclic compound (GO:0014070)", 0.002834455079654809, 11.480046269519955, 67.34086737964772, ["KYNU", "CCL5", "CCL2"], 0.04309332553305701, 0, 0], [60, "regulation of cell population proliferation (GO:0042127)", 0.003127902945521855, 3.023872679045093, 17.43986056298852, ["IL1A", "JUN", "IFITM1", "TNFRSF9", "CXCL1", "NMI", "CX3CL1", "CXCL5", "IFIT3", "HBEGF"], 0.04676214903555173, 0, 0], [61, "regulation of innate immune response (GO:0045088)", 0.0034047053494091115, 10.725094577553595, 60.94638896058672, ["IFI16", "CCL5", "NMI"], 0.05006591308885202, 0, 0], [62, "positive regulation of macrophage migration (GO:1905523)", 0.0035476988486272047, 25.433503836317136, 143.48199529383507, ["CCL5", "CX3CL1"], 0.051327191406751654, 0, 0], [63, "regulation of T cell migration (GO:2000404)", 0.003929871828835359, 24.019323671497585, 133.04659989721253, ["CCL20", "CCL5"], 0.05507960985102058, 0, 0], [64, "lipopolysaccharide-mediated signaling pathway (GO:0031663)", 0.003929871828835359, 24.019323671497585, 133.04659989721253, ["CCL5", "CCL2"], 0.05507960985102058, 0, 0], [65, "cell chemotaxis (GO:0060326)", 0.00420986393551384, 9.91008991008991, 54.21141210345841, ["CCL20", "CX3CL1", "HBEGF"], 0.058096122310091, 0, 0], [66, "apoptotic process (GO:0006915)", 0.004697707369715485, 4.892114944814557, 26.225066083456596, ["IL1A", "ADORA2A", "CASP4", "TLR2", "IFIT2"], 0.06384611379749683, 0, 0], [67, "response to copper ion (GO:0046688)", 0.0051852594222442485, 20.58488612836439, 108.31634113357939, ["IL1A", "MT2A"], 0.0694205627127327, 0, 0], [68, "positive regulation of hydrolase activity (GO:0051345)", 0.00537149602382962, 6.057011494252873, 31.657871979724053, ["CCL20", "CCL5", "CCL2", "CX3CL1"], 0.06947498433694002, 0, 0], [69, "regulation of cytokine production (GO:0001817)", 0.00549913476914464, 6.015220700152207, 31.29818288982711, ["IL1A", "IFI16", "IRF7", "SAA1"], 0.06947498433694002, 0, 0], [70, "cellular response to organic cyclic compound (GO:0071407)", 0.00549913476914464, 6.015220700152207, 31.29818288982711, ["HCN4", "CCL5", "CCL2", "SSH1"], 0.06947498433694002, 0, 0], [71, "response to cytokine (GO:0034097)", 0.00549913476914464, 6.015220700152207, 31.29818288982711, ["IFITM1", "GCH1", "KYNU", "XAF1"], 0.06947498433694002, 0, 0], [72, "protein kinase B signaling (GO:0043491)", 0.005639427655241041, 19.64822134387352, 101.73795368654676, ["CCL5", "CCL2"], 0.07025786953821131, 0, 0], [73, "positive regulation of type I interferon production (GO:0032481)", 0.0057211732839192704, 8.835164835164836, 45.62109258842689, ["IFI16", "IRF7", "TLR2"], 0.07029989637911761, 0, 0], [74, "receptor signaling pathway via STAT (GO:0097696)", 0.006111159851364195, 18.793005671077506, 95.79995291250643, ["CCL2", "NMI"], 0.07212776824570635, 0, 0], [75, "positive regulation of T cell migration (GO:2000406)", 0.006111159851364195, 18.793005671077506, 95.79995291250643, ["CCL20", "CCL5"], 0.07212776824570635, 0, 0], [76, "positive regulation of vascular endothelial growth factor production (GO:0010575)", 0.006111159851364195, 18.793005671077506, 95.79995291250643, ["CCBE1", "IL1A"], 0.07212776824570635, 0, 0], [77, "endothelial cell development (GO:0001885)", 0.006600284483977989, 18.009057971014492, 90.41704232490787, ["PPP1R16B", "ICAM1"], 0.07688902833932801, 0, 0], [78, "cellular response to cadmium ion (GO:0071276)", 0.007106631219173753, 17.28782608695652, 85.51815531993533, ["MT2A", "JUN"], 0.07968310254498571, 0, 0], [79, "regulation of toll-like receptor signaling pathway (GO:0034121)", 0.007106631219173753, 17.28782608695652, 85.51815531993533, ["IRF7", "TLR2"], 0.07968310254498571, 0, 0], [80, "regulation of vascular endothelial growth factor production (GO:0010574)", 0.007106631219173753, 17.28782608695652, 85.51815531993533, ["CCBE1", "IL1A"], 0.07968310254498571, 0, 0], [81, "negative regulation of defense response (GO:0031348)", 0.007519681311821682, 7.969981238273921, 38.97505347051986, ["IFI16", "SAA1", "NMI"], 0.08327350786054381, 0, 0], [82, "leukocyte cell-cell adhesion (GO:0007159)", 0.007630030913614265, 16.622073578595316, 81.04363548183322, ["CCL5", "ICAM1"], 0.08346509426234142, 0, 0], [83, "regulation of response to biotic stimulus (GO:0002831)", 0.008170315601077824, 16.005636070853463, 76.94305785437658, ["HERC5", "CX3CL1"], 0.08622085993137421, 0, 0], [84, "establishment of endothelial barrier (GO:0061028)", 0.008170315601077824, 16.005636070853463, 76.94305785437658, ["PPP1R16B", "ICAM1"], 0.08622085993137421, 0, 0], [85, "response to cadmium ion (GO:0046686)", 0.008170315601077824, 16.005636070853463, 76.94305785437658, ["MT2A", "JUN"], 0.08622085993137421, 0, 0], [86, "negative regulation of binding (GO:0051100)", 0.008270702258875568, 7.687524240465417, 36.86195438552468, ["JUN", "IFI16", "IFIT2"], 0.08626534797920214, 0, 0], [87, "negative regulation of cell population proliferation (GO:0008285)", 0.008958746183003248, 3.5704971971728003, 16.835340585107375, ["PARP10", "IL1A", "IFITM1", "CXCL1", "NMI", "IFIT3"], 0.0923677623695852, 0, 0], [88, "receptor signaling pathway via JAK-STAT (GO:0007259)", 0.00930087394698537, 14.900299850074962, 69.69834155839186, ["CCL2", "NMI"], 0.09269871033828753, 0, 0], [89, "negative regulation of DNA binding (GO:0043392)", 0.00930087394698537, 14.900299850074962, 69.69834155839186, ["JUN", "IFI16"], 0.09269871033828753, 0, 0], [90, "negative regulation of response to biotic stimulus (GO:0002832)", 0.00930087394698537, 14.900299850074962, 69.69834155839186, ["IFI16", "NMI"], 0.09269871033828753, 0, 0], [91, "regulation of cellular biosynthetic process (GO:0031326)", 0.009890817509289765, 14.402898550724638, 66.4859182031573, ["CCL5", "STC2"], 0.0964354707155752, 0, 0], [92, "modulation by host of symbiont process (GO:0051851)", 0.009890817509289765, 14.402898550724638, 66.4859182031573, ["JUN", "CCL5"], 0.0964354707155752, 0, 0], [93, "regulation of immune response (GO:0050776)", 0.010130883864957637, 5.011047619047619, 23.01156606999504, ["HERC5", "IFITM1", "IRF7", "ICAM1"], 0.09771400889104301, 0, 0], [94, "regulation of sprouting angiogenesis (GO:1903670)", 0.010496985856888533, 13.937587657784011, 63.50894747195799, ["PPP1R16B", "BMPER"], 0.10016804588967035, 0, 0], [95, "organic cyclic compound biosynthetic process (GO:1901362)", 0.011119216815215943, 13.501358695652174, 60.74369859051535, ["GCH1", "MOCOS"], 0.10498881561314423, 0, 0], [96, "cellular response to amyloid-beta (GO:1904646)", 0.011757349349970485, 13.091567852437418, 58.16945915571359, ["CASP4", "ICAM1"], 0.10985773298878672, 0, 0], [97, "regulation of GTPase activity (GO:0043087)", 0.012177042860321875, 4.737777777777778, 20.88508542064, ["CCL20", "CCL5", "CCL2", "CX3CL1"], 0.11132867529832005, 0, 0], [98, "positive regulation of innate immune response (GO:0045089)", 0.012411223556111487, 12.705882352941176, 55.768075499740505, ["CCL5", "NMI"], 0.11132867529832005, 0, 0], [99, "positive regulation of interferon-beta production (GO:0032728)", 0.012411223556111487, 12.705882352941176, 55.768075499740505, ["IRF7", "TLR2"], 0.11132867529832005, 0, 0], [100, "macrophage activation (GO:0042116)", 0.012411223556111487, 12.705882352941176, 55.768075499740505, ["NMI", "CX3CL1"], 0.11132867529832005, 0, 0], [101, "cellular metal ion homeostasis (GO:0006875)", 0.013007491824609675, 6.464476117941464, 28.07024079748959, ["STC2", "CCL5", "CLDN16"], 0.11391621887216145, 0, 0], [102, "positive regulation of calcium ion transport (GO:0051928)", 0.013080680650872497, 12.34223602484472, 53.52357397384211, ["CCL5", "CCL2"], 0.11391621887216145, 0, 0], [103, "positive regulation of signaling receptor activity (GO:2000273)", 0.013080680650872497, 12.34223602484472, 53.52357397384211, ["CCL2", "HBEGF"], 0.11391621887216145, 0, 0], [104, "negative regulation of innate immune response (GO:0045824)", 0.013765562969598598, 11.998792270531402, 51.42184708357683, ["IFI16", "NMI"], 0.1187279806127879, 0, 0], [105, "regulation of nitric-oxide synthase activity (GO:0050999)", 0.014465713956762766, 11.673913043478262, 49.45039194640452, ["IL1A", "GCH1"], 0.12357852780205905, 0, 0], [106, "regulation of interleukin-6 production (GO:0032675)", 0.015109203869631648, 6.1001335113484645, 25.574512017464105, ["IL1A", "CX3CL1", "TLR2"], 0.12785807425527912, 0, 0], [107, "cellular divalent inorganic cation homeostasis (GO:0072503)", 0.015477038787337694, 6.043345543345543, 25.191067795699258, ["MT2A", "STC2", "CCL5"], 0.12974676441347582, 0, 0], [108, "translesion synthesis (GO:0019985)", 0.01665622989862723, 10.796739130434782, 44.212333249908134, ["PARP10", "UBE2L6"], 0.13833924276915394, 0, 0], [109, "negative regulation of type I interferon production (GO:0032480)", 0.017415911980779488, 10.53287380699894, 42.66204670923194, ["HERC5", "UBE2L6"], 0.14010199121475655, 0, 0], [110, "DNA synthesis involved in DNA repair (GO:0000731)", 0.017415911980779488, 10.53287380699894, 42.66204670923194, ["PARP10", "UBE2L6"], 0.14010199121475655, 0, 0], [111, "regulation of endothelial cell apoptotic process (GO:2000351)", 0.01819009637610396, 10.281573498964804, 41.197010536699175, ["CCL2", "ICAM1"], 0.14010199121475655, 0, 0], [112, "response to amyloid-beta (GO:1904645)", 0.01819009637610396, 10.281573498964804, 41.197010536699175, ["CASP4", "ICAM1"], 0.14010199121475655, 0, 0], [113, "negative regulation of response to external stimulus (GO:0032102)", 0.018193231857994426, 5.67348303870043, 22.73197643285215, ["IFI16", "SAA1", "NMI"], 0.14010199121475655, 0, 0], [114, "positive regulation of GTPase activity (GO:0043547)", 0.01839806605874798, 4.168465608465609, 16.655144878594736, ["CCL20", "CCL5", "CCL2", "CX3CL1"], 0.14010199121475655, 0, 0], [115, "nervous system development (GO:0007399)", 0.018862665666369818, 3.0094310451453308, 11.949158647513364, ["ADORA2A", "MOBP", "CXCL1", "NRTN", "DCLK1", "IRF2BPL"], 0.14010199121475655, 0, 0], [116, "positive regulation of response to biotic stimulus (GO:0002833)", 0.018978633042899946, 10.04196157735086, 39.81076931220625, ["CCL5", "NMI"], 0.14010199121475655, 0, 0], [117, "postreplication repair (GO:0006301)", 0.019781373014179343, 9.813241106719367, 38.497487555319324, ["PARP10", "UBE2L6"], 0.14010199121475655, 0, 0], [118, "cellular response to lipid (GO:0071396)", 0.019840364122635554, 4.0704909560723515, 15.956474440940049, ["IL1A", "CCL2", "CXCL1", "CXCL5"], 0.14010199121475655, 0, 0], [119, "regulation of DNA binding (GO:0051101)", 0.020598168374574264, 9.594685990338164, 37.25187803675723, ["JUN", "IFI16"], 0.14010199121475655, 0, 0], [120, "positive regulation of cell-cell adhesion (GO:0022409)", 0.020598168374574264, 9.594685990338164, 37.25187803675723, ["CCL5", "CX3CL1"], 0.14010199121475655, 0, 0], [121, "regulation of T cell activation (GO:0050863)", 0.020598168374574264, 9.594685990338164, 37.25187803675723, ["CCL5", "CCL2"], 0.14010199121475655, 0, 0], [122, "regulation of tumor necrosis factor production (GO:0032680)", 0.020719197613640977, 5.390518572336754, 20.89739417347143, ["IL1A", "CX3CL1", "TLR2"], 0.14010199121475655, 0, 0], [123, "regulation of protein secretion (GO:0050708)", 0.02115800004221252, 5.346063772293281, 20.61301691989344, ["IL1A", "CCL5", "SAA1"], 0.14010199121475655, 0, 0], [124, "cellular protein modification process (GO:0006464)", 0.022068751300069578, 2.215693173821253, 8.449751178803925, ["HERC5", "IGFBP1", "PARP10", "STC2", "CCL2", "UBE2L6", "PI3", "PTPRH", "DCLK1", "SSH1"], 0.14010199121475655, 0, 0], [125, "regulation of interferon-beta production (GO:0032648)", 0.022273338845784817, 9.185476410730805, 34.94490389272714, ["IRF7", "TLR2"], 0.14010199121475655, 0, 0], [126, "regulation of smooth muscle cell proliferation (GO:0048660)", 0.022273338845784817, 9.185476410730805, 34.94490389272714, ["CCL5", "CX3CL1"], 0.14010199121475655, 0, 0], [127, "regulation of complement activation (GO:0030449)", 0.023131423352716708, 8.993659420289855, 33.87518721331595, ["C3AR1", "CFB"], 0.14010199121475655, 0, 0], [128, "receptor-mediated virion attachment to host cell (GO:0046813)", 0.023282278577421368, 53.5, 201.1633589371276, ["ICAM1"], 0.14010199121475655, 0, 0], [129, "negative regulation of organ growth (GO:0046621)", 0.023282278577421368, 53.5, 201.1633589371276, ["SLC6A4"], 0.14010199121475655, 0, 0], [130, "negative regulation of protein polyubiquitination (GO:1902915)", 0.023282278577421368, 53.5, 201.1633589371276, ["PARP10"], 0.14010199121475655, 0, 0], [131, "cellular response to cGMP (GO:0071321)", 0.023282278577421368, 53.5, 201.1633589371276, ["HCN4"], 0.14010199121475655, 0, 0], [132, "cellular response to erythropoietin (GO:0036018)", 0.023282278577421368, 53.5, 201.1633589371276, ["MT2A"], 0.14010199121475655, 0, 0], [133, "negative regulation of synapse organization (GO:1905809)", 0.023282278577421368, 53.5, 201.1633589371276, ["TLR2"], 0.14010199121475655, 0, 0], [134, "regulation of hippocampal neuron apoptotic process (GO:0110089)", 0.023282278577421368, 53.5, 201.1633589371276, ["CX3CL1"], 0.14010199121475655, 0, 0], [135, "regulation of hormone metabolic process (GO:0032350)", 0.023282278577421368, 53.5, 201.1633589371276, ["STC2"], 0.14010199121475655, 0, 0], [136, "negative regulation of vascular endothelial cell proliferation (GO:1905563)", 0.023282278577421368, 53.5, 201.1633589371276, ["CCL2"], 0.14010199121475655, 0, 0], [137, "regulation of interleukin-1 alpha production (GO:0032650)", 0.023282278577421368, 53.5, 201.1633589371276, ["CX3CL1"], 0.14010199121475655, 0, 0], [138, "regulation of kidney development (GO:0090183)", 0.023282278577421368, 53.5, 201.1633589371276, ["FOXD1"], 0.14010199121475655, 0, 0], [139, "dopamine biosynthetic process (GO:0042416)", 0.023282278577421368, 53.5, 201.1633589371276, ["GCH1"], 0.14010199121475655, 0, 0], [140, "glycerol biosynthetic process (GO:0006114)", 0.023282278577421368, 53.5, 201.1633589371276, ["PCK2"], 0.14010199121475655, 0, 0], [141, "response to cGMP (GO:0070305)", 0.023282278577421368, 53.5, 201.1633589371276, ["HCN4"], 0.14010199121475655, 0, 0], [142, "positive regulation of interleukin-18 production (GO:0032741)", 0.023282278577421368, 53.5, 201.1633589371276, ["TLR2"], 0.14010199121475655, 0, 0], [143, "SA node cell to atrial cardiac muscle cell signaling (GO:0086018)", 0.023282278577421368, 53.5, 201.1633589371276, ["HCN4"], 0.14010199121475655, 0, 0], [144, "positive regulation of natural killer cell chemotaxis (GO:2000503)", 0.023282278577421368, 53.5, 201.1633589371276, ["CCL5"], 0.14010199121475655, 0, 0], [145, "serotonin transport (GO:0006837)", 0.023282278577421368, 53.5, 201.1633589371276, ["SLC6A4"], 0.14010199121475655, 0, 0], [146, "serotonin uptake (GO:0051610)", 0.023282278577421368, 53.5, 201.1633589371276, ["SLC6A4"], 0.14010199121475655, 0, 0], [147, "T cell extravasation (GO:0072683)", 0.023282278577421368, 53.5, 201.1633589371276, ["CCL2"], 0.14010199121475655, 0, 0], [148, "membrane depolarization during SA node cell action potential (GO:0086046)", 0.023282278577421368, 53.5, 201.1633589371276, ["HCN4"], 0.14010199121475655, 0, 0], [149, "tryptophan catabolic process to kynurenine (GO:0019441)", 0.023282278577421368, 53.5, 201.1633589371276, ["KYNU"], 0.14010199121475655, 0, 0], [150, "regulation of response to external stimulus (GO:0032101)", 0.023428426624541226, 5.134290905944449, 19.27312780294187, ["HERC5", "CASP4", "CX3CL1"], 0.14010199121475655, 0, 0], [151, "sensory perception (GO:0007600)", 0.024002982032252727, 8.809671694764862, 32.85635073640704, ["ADORA2A", "CCL2"], 0.14046608365927363, 0, 0], [152, "sprouting angiogenesis (GO:0002040)", 0.024887872153036093, 8.63304347826087, 31.885063989274137, ["CCBE1", "BMPER"], 0.14046608365927363, 0, 0], [153, "regulation of immune effector process (GO:0002697)", 0.0257859520097423, 8.463341858482524, 30.958273416173974, ["C3AR1", "CFB"], 0.14046608365927363, 0, 0], [154, "positive regulation of NIK/NF-kappaB signaling (GO:1901224)", 0.0257859520097423, 8.463341858482524, 30.958273416173974, ["NMI", "TLR2"], 0.14046608365927363, 0, 0], [155, "regulation of humoral immune response (GO:0002920)", 0.02669708090688378, 8.300167224080267, 30.07317459219205, ["C3AR1", "CFB"], 0.14046608365927363, 0, 0], [156, "pteridine-containing compound biosynthetic process (GO:0042559)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["GCH1"], 0.14046608365927363, 0, 0], [157, "blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["BMPER"], 0.14046608365927363, 0, 0], [158, "negative regulation of myeloid cell apoptotic process (GO:0033033)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["IRF7"], 0.14046608365927363, 0, 0], [159, "negative regulation of neuron migration (GO:2001223)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["CX3CL1"], 0.14046608365927363, 0, 0], [160, "cell junction disassembly (GO:0150146)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["CX3CL1"], 0.14046608365927363, 0, 0], [161, "cellular response to bacterial lipopeptide (GO:0071221)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["TLR2"], 0.14046608365927363, 0, 0], [162, "cellular response to lipoteichoic acid (GO:0071223)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["TLR2"], 0.14046608365927363, 0, 0], [163, "regulation of glutamate receptor signaling pathway (GO:1900449)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["CX3CL1"], 0.14046608365927363, 0, 0], [164, "regulation of hormone biosynthetic process (GO:0046885)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["STC2"], 0.14046608365927363, 0, 0], [165, "regulation of immature T cell proliferation in thymus (GO:0033084)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["IL1A"], 0.14046608365927363, 0, 0], [166, "regulation of macrophage apoptotic process (GO:2000109)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["IRF7"], 0.14046608365927363, 0, 0], [167, "regulation of protein depolymerization (GO:1901879)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["MAP1B"], 0.14046608365927363, 0, 0], [168, "regulation of response to reactive oxygen species (GO:1901031)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["GCH1"], 0.14046608365927363, 0, 0], [169, "regulation of superoxide metabolic process (GO:0090322)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["GCH1"], 0.14046608365927363, 0, 0], [170, "positive regulation of cell-cell adhesion mediated by integrin (GO:0033634)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["CCL5"], 0.14046608365927363, 0, 0], [171, "hepatocyte differentiation (GO:0070365)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["PCK2"], 0.14046608365927363, 0, 0], [172, "positive regulation of I-kappaB phosphorylation (GO:1903721)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["CX3CL1"], 0.14046608365927363, 0, 0], [173, "response to lipoteichoic acid (GO:0070391)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["TLR2"], 0.14046608365927363, 0, 0], [174, "positive regulation of kidney development (GO:0090184)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["FOXD1"], 0.14046608365927363, 0, 0], [175, "positive regulation of microglial cell migration (GO:1904141)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["CX3CL1"], 0.14046608365927363, 0, 0], [176, "positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["CCBE1"], 0.14046608365927363, 0, 0], [177, "venous blood vessel morphogenesis (GO:0048845)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["CCBE1"], 0.14046608365927363, 0, 0], [178, "molybdopterin cofactor biosynthetic process (GO:0032324)", 0.027873983156466782, 42.79784946236559, 153.2189343652742, ["MOCOS"], 0.14046608365927363, 0, 0], [179, "cellular response to peptide (GO:1901653)", 0.02950736994340076, 7.846245059288537, 27.64322537448633, ["CASP4", "ICAM1"], 0.1478665410012876, 0, 0], [180, "regulation of chromatin assembly or disassembly (GO:0001672)", 0.03244433152831123, 35.66308243727599, 122.26123249735372, ["PARP10"], 0.14848247643313864, 0, 0], [181, "cellular cation homeostasis (GO:0030003)", 0.03244433152831123, 35.66308243727599, 122.26123249735372, ["CLDN16"], 0.14848247643313864, 0, 0], [182, "negative regulation of protein K63-linked ubiquitination (GO:1900045)", 0.03244433152831123, 35.66308243727599, 122.26123249735372, ["PARP10"], 0.14848247643313864, 0, 0], [183, "regulation of glial cell apoptotic process (GO:0034350)", 0.03244433152831123, 35.66308243727599, 122.26123249735372, ["CCL2"], 0.14848247643313864, 0, 0], [184, "negative regulation of T cell apoptotic process (GO:0070233)", 0.03244433152831123, 35.66308243727599, 122.26123249735372, ["CCL5"], 0.14848247643313864, 0, 0], [185, "regulation of I-kappaB phosphorylation (GO:1903719)", 0.03244433152831123, 35.66308243727599, 122.26123249735372, ["CX3CL1"], 0.14848247643313864, 0, 0], [186, "complement activation, alternative pathway (GO:0006957)", 0.03244433152831123, 35.66308243727599, 122.26123249735372, ["CFB"], 0.14848247643313864, 0, 0], [187, "regulation of microglial cell migration (GO:1904139)", 0.03244433152831123, 35.66308243727599, 122.26123249735372, ["CX3CL1"], 0.14848247643313864, 0, 0], [188, "oxygen transport (GO:0015671)", 0.03244433152831123, 35.66308243727599, 122.26123249735372, ["MB"], 0.14848247643313864, 0, 0], [189, "positive regulation of activation of Janus kinase activity (GO:0010536)", 0.03244433152831123, 35.66308243727599, 122.26123249735372, ["CCL5"], 0.14848247643313864, 0, 0], [190, "glial cell migration (GO:0008347)", 0.03244433152831123, 35.66308243727599, 122.26123249735372, ["CCL2"], 0.14848247643313864, 0, 0], [191, "response to host defenses (GO:0052200)", 0.03244433152831123, 35.66308243727599, 122.26123249735372, ["TLR2"], 0.14848247643313864, 0, 0], [192, "positive regulation of lymphocyte apoptotic process (GO:0070230)", 0.03244433152831123, 35.66308243727599, 122.26123249735372, ["CCL5"], 0.14848247643313864, 0, 0], [193, "SA node cell action potential (GO:0086015)", 0.03244433152831123, 35.66308243727599, 122.26123249735372, ["HCN4"], 0.14848247643313864, 0, 0], [194, "sinoatrial node development (GO:0003163)", 0.03244433152831123, 35.66308243727599, 122.26123249735372, ["HCN4"], 0.14848247643313864, 0, 0], [195, "vascular wound healing (GO:0061042)", 0.03244433152831123, 35.66308243727599, 122.26123249735372, ["MCAM"], 0.14848247643313864, 0, 0], [196, "modulation by symbiont of host defense response (GO:0052031)", 0.03244433152831123, 35.66308243727599, 122.26123249735372, ["TLR2"], 0.14848247643313864, 0, 0], [197, "positive regulation of interleukin-1 production (GO:0032732)", 0.03443932332146961, 7.190579710144927, 24.22187220688137, ["IFI16", "SAA1"], 0.1508322690767451, 0, 0], [198, "amyloid fibril formation (GO:1990000)", 0.035461726299078726, 7.072344975053457, 23.616690744660367, ["SAA1", "UBE2L6"], 0.1508322690767451, 0, 0], [199, "antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)", 0.03649582569857722, 6.957924263674614, 23.03460758568978, ["CXCL1", "CXCL5"], 0.1508322690767451, 0, 0], [200, "regulation of activation of Janus kinase activity (GO:0010533)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["CCL5"], 0.1508322690767451, 0, 0], [201, "regulation of alpha-beta T cell proliferation (GO:0046640)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["EBI3"], 0.1508322690767451, 0, 0], [202, "aromatic compound biosynthetic process (GO:0019438)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["GCH1"], 0.1508322690767451, 0, 0], [203, "regulation of apoptotic cell clearance (GO:2000425)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["CCL2"], 0.1508322690767451, 0, 0], [204, "negative regulation of glial cell apoptotic process (GO:0034351)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["CCL2"], 0.1508322690767451, 0, 0], [205, "benzene-containing compound metabolic process (GO:0042537)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["KYNU"], 0.1508322690767451, 0, 0], [206, "regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["HCN4"], 0.1508322690767451, 0, 0], [207, "negative regulation of microglial cell activation (GO:1903979)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["CX3CL1"], 0.1508322690767451, 0, 0], [208, "regulation of interleukin-18 production (GO:0032661)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["TLR2"], 0.1508322690767451, 0, 0], [209, "neurotransmitter reuptake (GO:0098810)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["SLC6A4"], 0.1508322690767451, 0, 0], [210, "regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["IRF7"], 0.1508322690767451, 0, 0], [211, "regulation of myeloid leukocyte differentiation (GO:0002761)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["IRF7"], 0.1508322690767451, 0, 0], [212, "regulation of protein K63-linked ubiquitination (GO:1900044)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["PARP10"], 0.1508322690767451, 0, 0], [213, "endosomal vesicle fusion (GO:0034058)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["SAMD9"], 0.1508322690767451, 0, 0], [214, "positive regulation of apoptotic cell clearance (GO:2000427)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["CCL2"], 0.1508322690767451, 0, 0], [215, "positive regulation of glial cell migration (GO:1903977)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["CX3CL1"], 0.1508322690767451, 0, 0], [216, "positive regulation of homotypic cell-cell adhesion (GO:0034112)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["CCL5"], 0.1508322690767451, 0, 0], [217, "integrin activation (GO:0033622)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["CX3CL1"], 0.1508322690767451, 0, 0], [218, "short-chain fatty acid catabolic process (GO:0019626)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["PCK2"], 0.1508322690767451, 0, 0], [219, "venous blood vessel development (GO:0060841)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["CCBE1"], 0.1508322690767451, 0, 0], [220, "monoamine transport (GO:0015844)", 0.03699342162417383, 30.566820276497698, 100.7792703363177, ["SLC6A4"], 0.1508322690767451, 0, 0], [221, "positive regulation of T cell proliferation (GO:0042102)", 0.03859859485749233, 6.739809782608695, 21.93497652529572, ["CCL5", "EBI3"], 0.15666488500982179, 0, 0], [222, "regulation of cellular extravasation (GO:0002691)", 0.04152135102145568, 26.74462365591398, 85.08929057374515, ["ICAM1"], 0.15984829127144096, 0, 0], [223, "regulation of cellular response to oxidative stress (GO:1900407)", 0.04152135102145568, 26.74462365591398, 85.08929057374515, ["GCH1"], 0.15984829127144096, 0, 0], [224, "cellular response to leptin stimulus (GO:0044320)", 0.04152135102145568, 26.74462365591398, 85.08929057374515, ["EBI3"], 0.15984829127144096, 0, 0], [225, "regulation of leukocyte mediated cytotoxicity (GO:0001910)", 0.04152135102145568, 26.74462365591398, 85.08929057374515, ["ICAM1"], 0.15984829127144096, 0, 0], [226, "positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589)", 0.04152135102145568, 26.74462365591398, 85.08929057374515, ["PPP1R16B"], 0.15984829127144096, 0, 0], [227, "glomerular filtration (GO:0003094)", 0.04152135102145568, 26.74462365591398, 85.08929057374515, ["MCAM"], 0.15984829127144096, 0, 0], [228, "response to vitamin (GO:0033273)", 0.04152135102145568, 26.74462365591398, 85.08929057374515, ["KYNU"], 0.15984829127144096, 0, 0], [229, "kynurenine metabolic process (GO:0070189)", 0.04152135102145568, 26.74462365591398, 85.08929057374515, ["KYNU"], 0.15984829127144096, 0, 0], [230, "synapse pruning (GO:0098883)", 0.04152135102145568, 26.74462365591398, 85.08929057374515, ["CX3CL1"], 0.15984829127144096, 0, 0], [231, "T-helper 1 type immune response (GO:0042088)", 0.04152135102145568, 26.74462365591398, 85.08929057374515, ["EBI3"], 0.15984829127144096, 0, 0], [232, "positive regulation of sequestering of triglyceride (GO:0010890)", 0.04152135102145568, 26.74462365591398, 85.08929057374515, ["PLIN2"], 0.15984829127144096, 0, 0], [233, "positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265)", 0.04152135102145568, 26.74462365591398, 85.08929057374515, ["CASP4"], 0.15984829127144096, 0, 0], [234, "defense response to Gram-positive bacterium (GO:0050830)", 0.04293883460255329, 6.342071611253197, 19.964705883356594, ["GBP2", "TLR2"], 0.16165459986901218, 0, 0], [235, "negative regulation of neuron apoptotic process (GO:0043524)", 0.04405122228301113, 6.249842470069313, 19.514521749182098, ["CCL2", "CX3CL1"], 0.16165459986901218, 0, 0], [236, "response to metal ion (GO:0010038)", 0.04405122228301113, 6.249842470069313, 19.514521749182098, ["IL1A", "MT2A"], 0.16165459986901218, 0, 0], [237, "positive regulation of protein secretion (GO:0050714)", 0.0451742926988683, 6.160248447204969, 19.07968843059069, ["IL1A", "TLR2"], 0.16165459986901218, 0, 0], [238, "protein poly-ADP-ribosylation (GO:0070212)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["PARP10"], 0.16165459986901218, 0, 0], [239, "amino sugar metabolic process (GO:0006040)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["GFPT2"], 0.16165459986901218, 0, 0], [240, "aromatic amino acid family metabolic process (GO:0009072)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["KYNU"], 0.16165459986901218, 0, 0], [241, "regulation of cell-cell adhesion mediated by integrin (GO:0033632)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["CCL5"], 0.16165459986901218, 0, 0], [242, "negative regulation of lymphocyte apoptotic process (GO:0070229)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["CCL5"], 0.16165459986901218, 0, 0], [243, "negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["JUN"], 0.16165459986901218, 0, 0], [244, "neuron remodeling (GO:0016322)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["CX3CL1"], 0.16165459986901218, 0, 0], [245, "cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["IRF7"], 0.16165459986901218, 0, 0], [246, "dicarboxylic acid biosynthetic process (GO:0043650)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["KYNU"], 0.16165459986901218, 0, 0], [247, "regulation of organ growth (GO:0046620)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["SLC6A4"], 0.16165459986901218, 0, 0], [248, "fructose 6-phosphate metabolic process (GO:0006002)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["GFPT2"], 0.16165459986901218, 0, 0], [249, "renal filtration (GO:0097205)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["MCAM"], 0.16165459986901218, 0, 0], [250, "granulocyte activation (GO:0036230)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["CCL5"], 0.16165459986901218, 0, 0], [251, "I-kappaB phosphorylation (GO:0007252)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["TLR2"], 0.16165459986901218, 0, 0], [252, "indolalkylamine catabolic process (GO:0046218)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["KYNU"], 0.16165459986901218, 0, 0], [253, "leptin-mediated signaling pathway (GO:0033210)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["EBI3"], 0.16165459986901218, 0, 0], [254, "positive regulation of T cell apoptotic process (GO:0070234)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["CCL5"], 0.16165459986901218, 0, 0], [255, "modulation by symbiont of host process (GO:0044003)", 0.04602821692612118, 23.77180406212664, 73.18151447362185, ["TLR2"], 0.16165459986901218, 0, 0], [256, "cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)", 0.046135537978224214, 3.8966243337500823, 11.986685645434692, ["CLDN16", "MYPN", "ICAM1"], 0.16165459986901218, 0, 0], [257, "cellular protein metabolic process (GO:0044267)", 0.046836545817770414, 2.658176066324861, 8.13692012825244, ["IGFBP1", "ADORA2A", "STC2", "RPL36A", "UBE2L6"], 0.1634723019398446, 0, 0], [258, "positive regulation of immune response (GO:0050778)", 0.048606378778094414, 5.906194163192376, 17.86033413867896, ["CCL5", "NMI"], 0.16433246962029338, 0, 0], [259, "positive regulation of T cell activation (GO:0050870)", 0.048606378778094414, 5.906194163192376, 17.86033413867896, ["CCL5", "CCL2"], 0.16433246962029338, 0, 0], [260, "actomyosin structure organization (GO:0031032)", 0.04977096302411214, 5.826086956521739, 17.480145823147954, ["FHDC1", "MYPN"], 0.16433246962029338, 0, 0], [261, "regulation of BMP signaling pathway (GO:0030510)", 0.04977096302411214, 5.826086956521739, 17.480145823147954, ["FOXD1", "BMPER"], 0.16433246962029338, 0, 0], [262, "positive regulation of interleukin-6 production (GO:0032755)", 0.04977096302411214, 5.826086956521739, 17.480145823147954, ["IL1A", "TLR2"], 0.16433246962029338, 0, 0], [263, "defense response to bacterium (GO:0042742)", 0.050222096683134314, 3.760337927967986, 11.248299506356856, ["PI3", "GBP2", "TLR2"], 0.16433246962029338, 0, 0], [264, "angiogenesis involved in wound healing (GO:0060055)", 0.05051411613720297, 21.393548387096775, 63.87049121569168, ["MCAM"], 0.16433246962029338, 0, 0], [265, "complement receptor mediated signaling pathway (GO:0002430)", 0.05051411613720297, 21.393548387096775, 63.87049121569168, ["C3AR1"], 0.16433246962029338, 0, 0], [266, "regulation of T cell apoptotic process (GO:0070232)", 0.05051411613720297, 21.393548387096775, 63.87049121569168, ["CCL5"], 0.16433246962029338, 0, 0], [267, "positive regulation of cellular extravasation (GO:0002693)", 0.05051411613720297, 21.393548387096775, 63.87049121569168, ["ICAM1"], 0.16433246962029338, 0, 0], [268, "positive regulation of epidermal growth factor-activated receptor activity (GO:0045741)", 0.05051411613720297, 21.393548387096775, 63.87049121569168, ["HBEGF"], 0.16433246962029338, 0, 0], [269, "interleukin-35-mediated signaling pathway (GO:0070757)", 0.05051411613720297, 21.393548387096775, 63.87049121569168, ["EBI3"], 0.16433246962029338, 0, 0], [270, "positive regulation of neuroblast proliferation (GO:0002052)", 0.05051411613720297, 21.393548387096775, 63.87049121569168, ["CX3CL1"], 0.16433246962029338, 0, 0], [271, "tetrahydrobiopterin metabolic process (GO:0046146)", 0.05051411613720297, 21.393548387096775, 63.87049121569168, ["GCH1"], 0.16433246962029338, 0, 0], [272, "tryptophan catabolic process (GO:0006569)", 0.05051411613720297, 21.393548387096775, 63.87049121569168, ["KYNU"], 0.16433246962029338, 0, 0], [273, "tryptophan metabolic process (GO:0006568)", 0.05051411613720297, 21.393548387096775, 63.87049121569168, ["KYNU"], 0.16433246962029338, 0, 0], [274, "UDP-N-acetylglucosamine biosynthetic process (GO:0006048)", 0.05051411613720297, 21.393548387096775, 63.87049121569168, ["GFPT2"], 0.16433246962029338, 0, 0], [275, "monocyte differentiation (GO:0030224)", 0.05051411613720297, 21.393548387096775, 63.87049121569168, ["IFI16"], 0.16433246962029338, 0, 0], [276, "negative regulation of cellular process (GO:0048523)", 0.050563836806244114, 2.3554383116883115, 7.029849560320316, ["IL1A", "IFITM1", "CXCL1", "NMI", "IFIT3", "TLR2"], 0.16433246962029338, 0, 0], [277, "positive regulation of tumor necrosis factor production (GO:0032760)", 0.05094562589081128, 5.748115942028986, 17.112120316828403, ["IL1A", "TLR2"], 0.16497554665724806, 0, 0], [278, "negative regulation of immune response (GO:0050777)", 0.05162240446151022, 3.7169858712715858, 11.016400888115356, ["ADORA2A", "IFI16", "NMI"], 0.16656581583444124, 0, 0], [279, "negative regulation of cytokine production (GO:0001818)", 0.054479566335605134, 3.63318804100927, 10.57232134020225, ["HERC5", "UBE2L6", "CX3CL1"], 0.16889141480205944, 0, 0], [280, "negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)", 0.05452890866813845, 5.5261984392419174, 16.075845456110244, ["IL1A", "ICAM1"], 0.16889141480205944, 0, 0], [281, "regulation of NIK/NF-kappaB signaling (GO:1901222)", 0.05452890866813845, 5.5261984392419174, 16.075845456110244, ["NMI", "TLR2"], 0.16889141480205944, 0, 0], [282, "positive regulation of cell adhesion (GO:0045785)", 0.05452890866813845, 5.5261984392419174, 16.075845456110244, ["CCL5", "SAA1"], 0.16889141480205944, 0, 0], [283, "MAPK cascade (GO:0000165)", 0.05465542350771995, 2.9144555927164624, 8.471467972767902, ["CCL5", "CCL2", "NRTN", "HBEGF"], 0.16889141480205944, 0, 0], [284, "protein mono-ADP-ribosylation (GO:0140289)", 0.05497914506376962, 19.44770283479961, 56.41392256593172, ["PARP10"], 0.16889141480205944, 0, 0], [285, "amino sugar biosynthetic process (GO:0046349)", 0.05497914506376962, 19.44770283479961, 56.41392256593172, ["GFPT2"], 0.16889141480205944, 0, 0], [286, "brain morphogenesis (GO:0048854)", 0.05497914506376962, 19.44770283479961, 56.41392256593172, ["SLC6A4"], 0.16889141480205944, 0, 0], [287, "negative regulation of leukocyte apoptotic process (GO:2000107)", 0.05497914506376962, 19.44770283479961, 56.41392256593172, ["IRF7"], 0.16889141480205944, 0, 0], [288, "catecholamine biosynthetic process (GO:0042423)", 0.05497914506376962, 19.44770283479961, 56.41392256593172, ["GCH1"], 0.16889141480205944, 0, 0], [289, "nucleotide-sugar metabolic process (GO:0009225)", 0.05497914506376962, 19.44770283479961, 56.41392256593172, ["GFPT2"], 0.16889141480205944, 0, 0], [290, "gas transport (GO:0015669)", 0.05497914506376962, 19.44770283479961, 56.41392256593172, ["MB"], 0.16889141480205944, 0, 0], [291, "positive regulation of protein maturation (GO:1903319)", 0.05497914506376962, 19.44770283479961, 56.41392256593172, ["CCBE1"], 0.16889141480205944, 0, 0], [292, "protein auto-ADP-ribosylation (GO:0070213)", 0.05497914506376962, 19.44770283479961, 56.41392256593172, ["PARP10"], 0.16889141480205944, 0, 0], [293, "positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557)", 0.05574271280314895, 5.455971381397909, 15.751436240724914, ["IL1A", "TLR2"], 0.17065260540759253, 0, 0], [294, "regulation of defense response (GO:0031347)", 0.058198696115285636, 5.320719269994632, 15.131552711449391, ["HERC5", "CASP4"], 0.17696349293359734, 0, 0], [295, "regulation of interleukin-1 beta production (GO:0032651)", 0.058198696115285636, 5.320719269994632, 15.131552711449391, ["IFI16", "CX3CL1"], 0.17696349293359734, 0, 0], [296, "pteridine-containing compound metabolic process (GO:0042558)", 0.059423399658711615, 17.82616487455197, 50.32446129740212, ["GCH1"], 0.17708567938160905, 0, 0], [297, "regulation of homotypic cell-cell adhesion (GO:0034110)", 0.059423399658711615, 17.82616487455197, 50.32446129740212, ["CCL5"], 0.17708567938160905, 0, 0], [298, "positive regulation of calcium ion import (GO:0090280)", 0.059423399658711615, 17.82616487455197, 50.32446129740212, ["CCL2"], 0.17708567938160905, 0, 0], [299, "Golgi ribbon formation (GO:0090161)", 0.059423399658711615, 17.82616487455197, 50.32446129740212, ["FHDC1"], 0.17708567938160905, 0, 0], [300, "macrophage activation involved in immune response (GO:0002281)", 0.059423399658711615, 17.82616487455197, 50.32446129740212, ["NMI"], 0.17708567938160905, 0, 0], [301, "UDP-N-acetylglucosamine metabolic process (GO:0006047)", 0.059423399658711615, 17.82616487455197, 50.32446129740212, ["GFPT2"], 0.17708567938160905, 0, 0], [302, "sodium ion transmembrane transport (GO:0035725)", 0.0632210029497673, 5.069309462915601, 13.996965194102321, ["HCN4", "SLC6A4"], 0.18415027978798165, 0, 0], [303, "activation of cysteine-type endopeptidase activity (GO:0097202)", 0.0638469754894786, 16.45409429280397, 45.269591284815306, ["IFI16"], 0.18415027978798165, 0, 0], [304, "negative regulation of neuroinflammatory response (GO:0150079)", 0.0638469754894786, 16.45409429280397, 45.269591284815306, ["CX3CL1"], 0.18415027978798165, 0, 0], [305, "cellular copper ion homeostasis (GO:0006878)", 0.0638469754894786, 16.45409429280397, 45.269591284815306, ["MT2A"], 0.18415027978798165, 0, 0], [306, "neurotransmitter biosynthetic process (GO:0042136)", 0.0638469754894786, 16.45409429280397, 45.269591284815306, ["SLC6A4"], 0.18415027978798165, 0, 0], [307, "nucleoside phosphate biosynthetic process (GO:1901293)", 0.0638469754894786, 16.45409429280397, 45.269591284815306, ["NMNAT1"], 0.18415027978798165, 0, 0], [308, "defense response to protozoan (GO:0042832)", 0.0638469754894786, 16.45409429280397, 45.269591284815306, ["GBP2"], 0.18415027978798165, 0, 0], [309, "positive regulation of macrophage chemotaxis (GO:0010759)", 0.0638469754894786, 16.45409429280397, 45.269591284815306, ["CCL5"], 0.18415027978798165, 0, 0], [310, "positive regulation of T cell chemotaxis (GO:0010820)", 0.0638469754894786, 16.45409429280397, 45.269591284815306, ["CCL5"], 0.18415027978798165, 0, 0], [311, "NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356)", 0.0638469754894786, 16.45409429280397, 45.269591284815306, ["PARP10"], 0.18415027978798165, 0, 0], [312, "sodium ion transport (GO:0006814)", 0.06708079110858839, 4.895750988142293, 13.227621763317467, ["HCN4", "SLC6A4"], 0.18758692874889674, 0, 0], [313, "acute-phase response (GO:0006953)", 0.06824996769314998, 15.278033794162827, 41.01507826972229, ["SAA1"], 0.18758692874889674, 0, 0], [314, "regulation of dephosphorylation (GO:0035303)", 0.06824996769314998, 15.278033794162827, 41.01507826972229, ["PPP1R16B"], 0.18758692874889674, 0, 0], [315, "cellular response to ATP (GO:0071318)", 0.06824996769314998, 15.278033794162827, 41.01507826972229, ["SSH1"], 0.18758692874889674, 0, 0], [316, "regulation of integrin activation (GO:0033623)", 0.06824996769314998, 15.278033794162827, 41.01507826972229, ["FBLIM1"], 0.18758692874889674, 0, 0], [317, "nitric oxide biosynthetic process (GO:0006809)", 0.06824996769314998, 15.278033794162827, 41.01507826972229, ["GCH1"], 0.18758692874889674, 0, 0], [318, "contractile actin filament bundle assembly (GO:0030038)", 0.06824996769314998, 15.278033794162827, 41.01507826972229, ["FHDC1"], 0.18758692874889674, 0, 0], [319, "regulation of microglial cell activation (GO:1903978)", 0.06824996769314998, 15.278033794162827, 41.01507826972229, ["CX3CL1"], 0.18758692874889674, 0, 0], [320, "endoplasmic reticulum tubular network organization (GO:0071786)", 0.06824996769314998, 15.278033794162827, 41.01507826972229, ["REEP2"], 0.18758692874889674, 0, 0], [321, "regulation of sequestering of triglyceride (GO:0010889)", 0.06824996769314998, 15.278033794162827, 41.01507826972229, ["PLIN2"], 0.18758692874889674, 0, 0], [322, "regulation of T cell chemotaxis (GO:0010819)", 0.06824996769314998, 15.278033794162827, 41.01507826972229, ["CCL5"], 0.18758692874889674, 0, 0], [323, "interleukin-27-mediated signaling pathway (GO:0070106)", 0.06824996769314998, 15.278033794162827, 41.01507826972229, ["EBI3"], 0.18758692874889674, 0, 0], [324, "positive regulation of pattern recognition receptor signaling pathway (GO:0062208)", 0.06824996769314998, 15.278033794162827, 41.01507826972229, ["TLR2"], 0.18758692874889674, 0, 0], [325, "stress fiber assembly (GO:0043149)", 0.06824996769314998, 15.278033794162827, 41.01507826972229, ["FHDC1"], 0.18758692874889674, 0, 0], [326, "positive regulation of sprouting angiogenesis (GO:1903672)", 0.06824996769314998, 15.278033794162827, 41.01507826972229, ["BMPER"], 0.18758692874889674, 0, 0], [327, "toll-like receptor signaling pathway (GO:0002224)", 0.06838453255394562, 4.8404982901807525, 12.985162400470038, ["NMI", "TLR2"], 0.18758692874889674, 0, 0], [328, "cellular response to fibroblast growth factor stimulus (GO:0044344)", 0.06969666849299903, 4.786473429951691, 12.74926383946572, ["CCL5", "CCL2"], 0.18884442449305242, 0, 0], [329, "positive regulation of cellular component biogenesis (GO:0044089)", 0.06969666849299903, 4.786473429951691, 12.74926383946572, ["CX3CL1", "TRABD2A"], 0.18884442449305242, 0, 0], [330, "regulation of angiogenesis (GO:0045765)", 0.07068187345670315, 3.2482417582417584, 8.606431330732383, ["PPP1R16B", "IL1A", "BMPER"], 0.18884442449305242, 0, 0], [331, "aromatic amino acid family catabolic process (GO:0009074)", 0.07263247095886631, 14.258781362007168, 37.3914183271943, ["KYNU"], 0.18884442449305242, 0, 0], [332, "regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587)", 0.07263247095886631, 14.258781362007168, 37.3914183271943, ["PPP1R16B"], 0.18884442449305242, 0, 0], [333, "negative regulation of macrophage activation (GO:0043031)", 0.07263247095886631, 14.258781362007168, 37.3914183271943, ["CX3CL1"], 0.18884442449305242, 0, 0], [334, "regulation of defense response to virus (GO:0050688)", 0.07263247095886631, 14.258781362007168, 37.3914183271943, ["HERC5"], 0.18884442449305242, 0, 0], [335, "regulation of interleukin-1 production (GO:0032652)", 0.07263247095886631, 14.258781362007168, 37.3914183271943, ["SAA1"], 0.18884442449305242, 0, 0], [336, "neutrophil activation (GO:0042119)", 0.07263247095886631, 14.258781362007168, 37.3914183271943, ["CCL5"], 0.18884442449305242, 0, 0], [337, "nitric oxide metabolic process (GO:0046209)", 0.07263247095886631, 14.258781362007168, 37.3914183271943, ["GCH1"], 0.18884442449305242, 0, 0], [338, "dendrite self-avoidance (GO:0070593)", 0.07263247095886631, 14.258781362007168, 37.3914183271943, ["MYPN"], 0.18884442449305242, 0, 0], [339, "dendritic cell chemotaxis (GO:0002407)", 0.07263247095886631, 14.258781362007168, 37.3914183271943, ["CCL5"], 0.18884442449305242, 0, 0], [340, "regulation of monocyte differentiation (GO:0045655)", 0.07263247095886631, 14.258781362007168, 37.3914183271943, ["IRF7"], 0.18884442449305242, 0, 0], [341, "positive regulation by host of viral transcription (GO:0043923)", 0.07263247095886631, 14.258781362007168, 37.3914183271943, ["JUN"], 0.18884442449305242, 0, 0], [342, "positive regulation of alpha-beta T cell proliferation (GO:0046641)", 0.07263247095886631, 14.258781362007168, 37.3914183271943, ["EBI3"], 0.18884442449305242, 0, 0], [343, "filopodium assembly (GO:0046847)", 0.07263247095886631, 14.258781362007168, 37.3914183271943, ["ARHGEF4"], 0.18884442449305242, 0, 0], [344, "positive regulation of endothelial cell apoptotic process (GO:2000353)", 0.07263247095886631, 14.258781362007168, 37.3914183271943, ["CCL2"], 0.18884442449305242, 0, 0], [345, "male meiosis I (GO:0007141)", 0.07263247095886631, 14.258781362007168, 37.3914183271943, ["HSF2BP"], 0.18884442449305242, 0, 0], [346, "positive regulation of cellular process (GO:0048522)", 0.07410992547737287, 2.1244309002790422, 5.528206428648133, ["CCL5", "SAA1", "CX3CL1", "CXCL5", "TLR2", "HBEGF"], 0.19149275469141483, 0, 0], [347, "calcium ion homeostasis (GO:0055074)", 0.07637959252422546, 4.533409610983981, 11.660109641099526, ["STC2", "CCL5"], 0.19149275469141483, 0, 0], [348, "positive regulation of gene expression (GO:0010628)", 0.07687318414205928, 2.2882952912632795, 5.870846220953965, ["IL1A", "FOXD1", "IFI16", "SAA1", "TLR2"], 0.19149275469141483, 0, 0], [349, "regulation of cell killing (GO:0031341)", 0.07699457959048413, 13.366935483870968, 34.2730933217087, ["ICAM1"], 0.19149275469141483, 0, 0], [350, "negative regulation of phagocytosis (GO:0050765)", 0.07699457959048413, 13.366935483870968, 34.2730933217087, ["TLR2"], 0.19149275469141483, 0, 0], [351, "negative regulation of viral entry into host cell (GO:0046597)", 0.07699457959048413, 13.366935483870968, 34.2730933217087, ["IFITM1"], 0.19149275469141483, 0, 0], [352, "copper ion homeostasis (GO:0055070)", 0.07699457959048413, 13.366935483870968, 34.2730933217087, ["MT2A"], 0.19149275469141483, 0, 0], [353, "regulation of neuroblast proliferation (GO:1902692)", 0.07699457959048413, 13.366935483870968, 34.2730933217087, ["CX3CL1"], 0.19149275469141483, 0, 0], [354, "diol biosynthetic process (GO:0034312)", 0.07699457959048413, 13.366935483870968, 34.2730933217087, ["GCH1"], 0.19149275469141483, 0, 0], [355, "membrane depolarization during cardiac muscle cell action potential (GO:0086012)", 0.07699457959048413, 13.366935483870968, 34.2730933217087, ["HCN4"], 0.19149275469141483, 0, 0], [356, "positive regulation of smooth muscle cell migration (GO:0014911)", 0.07699457959048413, 13.366935483870968, 34.2730933217087, ["CCL5"], 0.19149275469141483, 0, 0], [357, "protein autoprocessing (GO:0016540)", 0.07699457959048413, 13.366935483870968, 34.2730933217087, ["CASP4"], 0.19149275469141483, 0, 0], [358, "positive regulation of multicellular organismal process (GO:0051240)", 0.07965496475777052, 2.550016291951776, 6.451671046070243, ["IL1A", "FOXD1", "IFI16", "SAA1"], 0.19149275469141483, 0, 0], [359, "regulation of adaptive immune response (GO:0002819)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["IRF7"], 0.19149275469141483, 0, 0], [360, "negative regulation of fibroblast proliferation (GO:0048147)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["PARP10"], 0.19149275469141483, 0, 0], [361, "cellular response to glucocorticoid stimulus (GO:0071385)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["PCK2"], 0.19149275469141483, 0, 0], [362, "cellular response to zinc ion (GO:0071294)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["MT2A"], 0.19149275469141483, 0, 0], [363, "neuron maturation (GO:0042551)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["CX3CL1"], 0.19149275469141483, 0, 0], [364, "regulation of membrane depolarization (GO:0003254)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["HCN4"], 0.19149275469141483, 0, 0], [365, "nucleotide biosynthetic process (GO:0009165)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["NMNAT1"], 0.19149275469141483, 0, 0], [366, "dendritic cell migration (GO:0036336)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["CCL5"], 0.19149275469141483, 0, 0], [367, "endothelial cell proliferation (GO:0001935)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["BMPER"], 0.19149275469141483, 0, 0], [368, "positive chemotaxis (GO:0050918)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["CX3CL1"], 0.19149275469141483, 0, 0], [369, "epithelial structure maintenance (GO:0010669)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["TFF1"], 0.19149275469141483, 0, 0], [370, "positive regulation of cell adhesion mediated by integrin (GO:0033630)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["CCL5"], 0.19149275469141483, 0, 0], [371, "regulation of vascular endothelial cell proliferation (GO:1905562)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["CCL2"], 0.19149275469141483, 0, 0], [372, "response to interferon-alpha (GO:0035455)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["IFITM1"], 0.19149275469141483, 0, 0], [373, "positive regulation of lymphocyte chemotaxis (GO:0140131)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["CCL5"], 0.19149275469141483, 0, 0], [374, "positive regulation of nitric-oxide synthase activity (GO:0051000)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["GCH1"], 0.19149275469141483, 0, 0], [375, "sodium ion import across plasma membrane (GO:0098719)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["HCN4"], 0.19149275469141483, 0, 0], [376, "leukocyte tethering or rolling (GO:0050901)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["ADD2"], 0.19149275469141483, 0, 0], [377, "synaptic transmission, glutamatergic (GO:0035249)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["GRID1"], 0.19149275469141483, 0, 0], [378, "maintenance of gastrointestinal epithelium (GO:0030277)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["TFF1"], 0.19149275469141483, 0, 0], [379, "T cell migration (GO:0072678)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["CCL20"], 0.19149275469141483, 0, 0], [380, "positive regulation of synaptic transmission, glutamatergic (GO:0051968)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["CCL2"], 0.19149275469141483, 0, 0], [381, "triglyceride biosynthetic process (GO:0019432)", 0.08133638744417955, 12.580012650221379, 31.565287091339382, ["PCK2"], 0.19149275469141483, 0, 0], [382, "intrinsic apoptotic signaling pathway (GO:0097193)", 0.08325685105592927, 4.305652173913043, 10.70309720614634, ["IFI16", "CASP4"], 0.1925694616251597, 0, 0], [383, "cellular response to organonitrogen compound (GO:0071417)", 0.08465451941853727, 4.262806715454154, 10.525623369484789, ["HCN4", "SSH1"], 0.1925694616251597, 0, 0], [384, "actin filament capping (GO:0051693)", 0.0856579879469774, 11.8805256869773, 29.195118234670645, ["ADD2"], 0.1925694616251597, 0, 0], [385, "pyroptosis (GO:0070269)", 0.0856579879469774, 11.8805256869773, 29.195118234670645, ["CASP4"], 0.1925694616251597, 0, 0], [386, "barbed-end actin filament capping (GO:0051016)", 0.0856579879469774, 11.8805256869773, 29.195118234670645, ["ADD2"], 0.1925694616251597, 0, 0], [387, "branching involved in ureteric bud morphogenesis (GO:0001658)", 0.0856579879469774, 11.8805256869773, 29.195118234670645, ["FOXD1"], 0.1925694616251597, 0, 0], [388, "negative regulation of nervous system development (GO:0051961)", 0.0856579879469774, 11.8805256869773, 29.195118234670645, ["TLR2"], 0.1925694616251597, 0, 0], [389, "cellular response to copper ion (GO:0071280)", 0.0856579879469774, 11.8805256869773, 29.195118234670645, ["MT2A"], 0.1925694616251597, 0, 0], [390, "regulation of insulin-like growth factor receptor signaling pathway (GO:0043567)", 0.0856579879469774, 11.8805256869773, 29.195118234670645, ["IGFBP1"], 0.1925694616251597, 0, 0], [391, "neuromuscular process (GO:0050905)", 0.0856579879469774, 11.8805256869773, 29.195118234670645, ["GCH1"], 0.1925694616251597, 0, 0], [392, "nucleotide-sugar biosynthetic process (GO:0009226)", 0.0856579879469774, 11.8805256869773, 29.195118234670645, ["GFPT2"], 0.1925694616251597, 0, 0], [393, "diol metabolic process (GO:0034311)", 0.0856579879469774, 11.8805256869773, 29.195118234670645, ["GCH1"], 0.1925694616251597, 0, 0], [394, "dopamine metabolic process (GO:0042417)", 0.0856579879469774, 11.8805256869773, 29.195118234670645, ["GCH1"], 0.1925694616251597, 0, 0], [395, "regulation of vascular endothelial growth factor signaling pathway (GO:1900746)", 0.0856579879469774, 11.8805256869773, 29.195118234670645, ["CCBE1"], 0.1925694616251597, 0, 0], [396, "response to ATP (GO:0033198)", 0.0856579879469774, 11.8805256869773, 29.195118234670645, ["SSH1"], 0.1925694616251597, 0, 0], [397, "positive regulation of monocyte chemotaxis (GO:0090026)", 0.0856579879469774, 11.8805256869773, 29.195118234670645, ["CCL5"], 0.1925694616251597, 0, 0], [398, "leukocyte adhesion to vascular endothelial cell (GO:0061756)", 0.0856579879469774, 11.8805256869773, 29.195118234670645, ["ADD2"], 0.1925694616251597, 0, 0], [399, "myeloid cell activation involved in immune response (GO:0002275)", 0.0856579879469774, 11.8805256869773, 29.195118234670645, ["NMI"], 0.1925694616251597, 0, 0], [400, "regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)", 0.0888901994044787, 4.139214046822742, 10.018360731365734, ["PPP1R16B", "CCL5"], 0.1953841362929668, 0, 0], [401, "adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)", 0.08995947412374057, 11.254668930390492, 27.105699605992406, ["EBI3"], 0.1953841362929668, 0, 0], [402, "negative regulation of dephosphorylation (GO:0035305)", 0.08995947412374057, 11.254668930390492, 27.105699605992406, ["PPP1R16B"], 0.1953841362929668, 0, 0], [403, "calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338)", 0.08995947412374057, 11.254668930390492, 27.105699605992406, ["CLDN16"], 0.1953841362929668, 0, 0], [404, "cellular response to interferon-beta (GO:0035458)", 0.08995947412374057, 11.254668930390492, 27.105699605992406, ["IFI16"], 0.1953841362929668, 0, 0], [405, "regulation of granulocyte chemotaxis (GO:0071622)", 0.08995947412374057, 11.254668930390492, 27.105699605992406, ["CCL5"], 0.1953841362929668, 0, 0], [406, "negative regulation of viral life cycle (GO:1903901)", 0.08995947412374057, 11.254668930390492, 27.105699605992406, ["IFITM1"], 0.1953841362929668, 0, 0], [407, "energy reserve metabolic process (GO:0006112)", 0.08995947412374057, 11.254668930390492, 27.105699605992406, ["GFPT2"], 0.1953841362929668, 0, 0], [408, "positive regulation of alpha-beta T cell activation (GO:0046635)", 0.08995947412374057, 11.254668930390492, 27.105699605992406, ["EBI3"], 0.1953841362929668, 0, 0], [409, "regulation of smooth muscle cell migration (GO:0014910)", 0.08995947412374057, 11.254668930390492, 27.105699605992406, ["CCL5"], 0.1953841362929668, 0, 0], [410, "positive regulation of interferon-alpha production (GO:0032727)", 0.08995947412374057, 11.254668930390492, 27.105699605992406, ["IRF7"], 0.1953841362929668, 0, 0], [411, "positive regulation of protein processing (GO:0010954)", 0.08995947412374057, 11.254668930390492, 27.105699605992406, ["CCBE1"], 0.1953841362929668, 0, 0], [412, "toll-like receptor 4 signaling pathway (GO:0034142)", 0.08995947412374057, 11.254668930390492, 27.105699605992406, ["NMI"], 0.1953841362929668, 0, 0], [413, "myeloid cell development (GO:0061515)", 0.08995947412374057, 11.254668930390492, 27.105699605992406, ["TLR2"], 0.1953841362929668, 0, 0], [414, "purinergic nucleotide receptor signaling pathway (GO:0035590)", 0.09424093857799493, 10.691397849462366, 25.252018992111125, ["C3AR1"], 0.2012717188201463, 0, 0], [415, "calcium-mediated signaling using intracellular calcium source (GO:0035584)", 0.09424093857799493, 10.691397849462366, 25.252018992111125, ["CCL20"], 0.2012717188201463, 0, 0], [416, "regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664)", 0.09424093857799493, 10.691397849462366, 25.252018992111125, ["CX3CL1"], 0.2012717188201463, 0, 0], [417, "positive regulation of lipid storage (GO:0010884)", 0.09424093857799493, 10.691397849462366, 25.252018992111125, ["PLIN2"], 0.2012717188201463, 0, 0], [418, "sensory perception of pain (GO:0019233)", 0.09424093857799493, 10.691397849462366, 25.252018992111125, ["CCL2"], 0.2012717188201463, 0, 0], [419, "intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)", 0.09424093857799493, 10.691397849462366, 25.252018992111125, ["IFI16"], 0.2012717188201463, 0, 0], [420, "positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707)", 0.09424093857799493, 10.691397849462366, 25.252018992111125, ["JUN"], 0.2012717188201463, 0, 0], [421, "response to endoplasmic reticulum stress (GO:0034976)", 0.09463378940922954, 3.9851046698872787, 9.395843413311301, ["JUN", "CASP4"], 0.2016306629455556, 0, 0], [422, "regulation of Wnt signaling pathway (GO:0030111)", 0.09608620817895712, 3.9483446350219387, 9.249034771851605, ["TLR2", "TRABD2A"], 0.2042401154893946, 0, 0], [423, "negative regulation of protein dephosphorylation (GO:0035308)", 0.09850247349031198, 10.181771633384537, 23.598023514902643, ["PPP1R16B"], 0.20644093159067722, 0, 0], [424, "regulation of macrophage chemotaxis (GO:0010758)", 0.09850247349031198, 10.181771633384537, 23.598023514902643, ["CCL5"], 0.20644093159067722, 0, 0], [425, "positive regulation of DNA-templated transcription, initiation (GO:2000144)", 0.09850247349031198, 10.181771633384537, 23.598023514902643, ["JUN"], 0.20644093159067722, 0, 0], [426, "positive regulation of neural precursor cell proliferation (GO:2000179)", 0.09850247349031198, 10.181771633384537, 23.598023514902643, ["CX3CL1"], 0.20644093159067722, 0, 0], [427, "microglial cell activation (GO:0001774)", 0.09850247349031198, 10.181771633384537, 23.598023514902643, ["CX3CL1"], 0.20644093159067722, 0, 0], [428, "positive regulation of translational initiation (GO:0045948)", 0.09850247349031198, 10.181771633384537, 23.598023514902643, ["CCL5"], 0.20644093159067722, 0, 0], [429, "negative regulation of cell motility (GO:2000146)", 0.10048164784559761, 3.842003105590062, 8.828078574689023, ["IFITM1", "CX3CL1"], 0.20960939097093267, 0, 0], [430, "response to lipid (GO:0033993)", 0.10048164784559761, 3.842003105590062, 8.828078574689023, ["GCH1", "PCK2"], 0.20960939097093267, 0, 0], [431, "negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240)", 0.10274417059524597, 9.718475073313783, 22.114517934967417, ["IL1A"], 0.2104144315614969, 0, 0], [432, "negative regulation of G protein-coupled receptor signaling pathway (GO:0045744)", 0.10274417059524597, 9.718475073313783, 22.114517934967417, ["CCL5"], 0.2104144315614969, 0, 0], [433, "regulation of cysteine-type endopeptidase activity (GO:2000116)", 0.10274417059524597, 9.718475073313783, 22.114517934967417, ["IFI16"], 0.2104144315614969, 0, 0], [434, "negative regulation of signal transduction in absence of ligand (GO:1901099)", 0.10274417059524597, 9.718475073313783, 22.114517934967417, ["IL1A"], 0.2104144315614969, 0, 0], [435, "nucleotide metabolic process (GO:0009117)", 0.10274417059524597, 9.718475073313783, 22.114517934967417, ["NMNAT1"], 0.2104144315614969, 0, 0], [436, "regulation of mononuclear cell migration (GO:0071675)", 0.10274417059524597, 9.718475073313783, 22.114517934967417, ["CCL5"], 0.2104144315614969, 0, 0], [437, "regulation of supramolecular fiber organization (GO:1902903)", 0.10274417059524597, 9.718475073313783, 22.114517934967417, ["MAP1B"], 0.2104144315614969, 0, 0], [438, "positive regulation of epithelial cell apoptotic process (GO:1904037)", 0.10274417059524597, 9.718475073313783, 22.114517934967417, ["CCL2"], 0.2104144315614969, 0, 0], [439, "regulation of protein-containing complex assembly (GO:0043254)", 0.10344286054156288, 3.774218154080854, 8.562704185822335, ["FBLIM1", "TRABD2A"], 0.21088237705859522, 0, 0], [440, "positive regulation of angiogenesis (GO:0045766)", 0.10344286054156288, 3.774218154080854, 8.562704185822335, ["IL1A", "BMPER"], 0.21088237705859522, 0, 0], [441, "axonogenesis (GO:0007409)", 0.10376716990741684, 2.735985533453888, 6.1986642568655315, ["MAP1B", "NRTN", "MYPN"], 0.21106383538991588, 0, 0], [442, "regulation of protein binding (GO:0043393)", 0.10642798187813117, 3.7087706146926536, 8.30870966344855, ["IFIT2", "ADD2"], 0.21417100619277782, 0, 0], [443, "axon extension (GO:0048675)", 0.10696612126462036, 9.295465170640487, 20.777624554547717, ["MAP1B"], 0.21417100619277782, 0, 0], [444, "negative regulation of NIK/NF-kappaB signaling (GO:1901223)", 0.10696612126462036, 9.295465170640487, 20.777624554547717, ["NMI"], 0.21417100619277782, 0, 0], [445, "cholesterol efflux (GO:0033344)", 0.10696612126462036, 9.295465170640487, 20.777624554547717, ["STX12"], 0.21417100619277782, 0, 0], [446, "regulation of monooxygenase activity (GO:0032768)", 0.10696612126462036, 9.295465170640487, 20.777624554547717, ["IL1A"], 0.21417100619277782, 0, 0], [447, "immune response-activating cell surface receptor signaling pathway (GO:0002429)", 0.10696612126462036, 9.295465170640487, 20.777624554547717, ["C3AR1"], 0.21417100619277782, 0, 0], [448, "positive regulation of phospholipase activity (GO:0010518)", 0.10696612126462036, 9.295465170640487, 20.777624554547717, ["CCL5"], 0.21417100619277782, 0, 0], [449, "negative regulation of cell junction assembly (GO:1901889)", 0.11116841641092283, 8.907706093189963, 19.567637811028366, ["TLR2"], 0.21772504262139253, 0, 0], [450, "regulation of calcium ion import (GO:0090279)", 0.11116841641092283, 8.907706093189963, 19.567637811028366, ["CCL2"], 0.21772504262139253, 0, 0], [451, "regulation of cardiac muscle cell action potential (GO:0098901)", 0.11116841641092283, 8.907706093189963, 19.567637811028366, ["HCN4"], 0.21772504262139253, 0, 0], [452, "cardiac conduction system development (GO:0003161)", 0.11116841641092283, 8.907706093189963, 19.567637811028366, ["HCN4"], 0.21772504262139253, 0, 0], [453, "cellular response to hexose stimulus (GO:0071331)", 0.11116841641092283, 8.907706093189963, 19.567637811028366, ["PCK2"], 0.21772504262139253, 0, 0], [454, "regulation of interferon-alpha production (GO:0032647)", 0.11116841641092283, 8.907706093189963, 19.567637811028366, ["IRF7"], 0.21772504262139253, 0, 0], [455, "regulation of microtubule depolymerization (GO:0031114)", 0.11116841641092283, 8.907706093189963, 19.567637811028366, ["MAP1B"], 0.21772504262139253, 0, 0], [456, "energy derivation by oxidation of organic compounds (GO:0015980)", 0.11116841641092283, 8.907706093189963, 19.567637811028366, ["GFPT2"], 0.21772504262139253, 0, 0], [457, "regulation of protein processing (GO:0070613)", 0.11116841641092283, 8.907706093189963, 19.567637811028366, ["CCBE1"], 0.21772504262139253, 0, 0], [458, "negative regulation of actin filament polymerization (GO:0030837)", 0.11116841641092283, 8.907706093189963, 19.567637811028366, ["SSH1"], 0.21772504262139253, 0, 0], [459, "cellular response to organic substance (GO:0071310)", 0.11399083986480084, 3.554617319439454, 7.719339152464933, ["CCL5", "CCL2"], 0.22014889035157417, 0, 0], [460, "positive regulation of intracellular signal transduction (GO:1902533)", 0.11458810001818369, 2.0109451909696983, 4.356534424361555, ["CCL5", "NMI", "CX3CL1", "TLR2", "HBEGF"], 0.22014889035157417, 0, 0], [461, "regulation of actin filament bundle assembly (GO:0032231)", 0.11535114656102549, 8.550967741935484, 18.46816083576708, ["CX3CL1"], 0.22014889035157417, 0, 0], [462, "negative regulation of interleukin-1 beta production (GO:0032691)", 0.11535114656102549, 8.550967741935484, 18.46816083576708, ["CX3CL1"], 0.22014889035157417, 0, 0], [463, "regulation of monocyte chemotaxis (GO:0090025)", 0.11535114656102549, 8.550967741935484, 18.46816083576708, ["CCL5"], 0.22014889035157417, 0, 0], [464, "glial cell development (GO:0021782)", 0.11535114656102549, 8.550967741935484, 18.46816083576708, ["TLR2"], 0.22014889035157417, 0, 0], [465, "positive regulation of interleukin-2 production (GO:0032743)", 0.11535114656102549, 8.550967741935484, 18.46816083576708, ["IL1A"], 0.22014889035157417, 0, 0], [466, "lamellipodium assembly (GO:0030032)", 0.11535114656102549, 8.550967741935484, 18.46816083576708, ["ARHGEF4"], 0.22014889035157417, 0, 0], [467, "meiosis I (GO:0007127)", 0.11535114656102549, 8.550967741935484, 18.46816083576708, ["HSF2BP"], 0.22014889035157417, 0, 0], [468, "membrane depolarization during action potential (GO:0086010)", 0.11535114656102549, 8.550967741935484, 18.46816083576708, ["HCN4"], 0.22014889035157417, 0, 0], [469, "metanephros development (GO:0001656)", 0.11535114656102549, 8.550967741935484, 18.46816083576708, ["FOXD1"], 0.22014889035157417, 0, 0], [470, "mononuclear cell differentiation (GO:1903131)", 0.11535114656102549, 8.550967741935484, 18.46816083576708, ["IFI16"], 0.22014889035157417, 0, 0], [471, "acute inflammatory response (GO:0002526)", 0.1195144018245045, 8.221670802315964, 17.465446543649804, ["SAA1"], 0.22334253840954277, 0, 0], [472, "negative regulation of endothelial cell apoptotic process (GO:2000352)", 0.1195144018245045, 8.221670802315964, 17.465446543649804, ["ICAM1"], 0.22334253840954277, 0, 0], [473, "regulation of cardiac muscle cell contraction (GO:0086004)", 0.1195144018245045, 8.221670802315964, 17.465446543649804, ["HCN4"], 0.22334253840954277, 0, 0], [474, "negative regulation of protein polymerization (GO:0032272)", 0.1195144018245045, 8.221670802315964, 17.465446543649804, ["SSH1"], 0.22334253840954277, 0, 0], [475, "regulation of epidermal growth factor-activated receptor activity (GO:0007176)", 0.1195144018245045, 8.221670802315964, 17.465446543649804, ["HBEGF"], 0.22334253840954277, 0, 0], [476, "positive regulation of BMP signaling pathway (GO:0030513)", 0.1195144018245045, 8.221670802315964, 17.465446543649804, ["FOXD1"], 0.22334253840954277, 0, 0], [477, "positive regulation of calcium ion transmembrane transport (GO:1904427)", 0.1195144018245045, 8.221670802315964, 17.465446543649804, ["CX3CL1"], 0.22334253840954277, 0, 0], [478, "regulation of vasculature development (GO:1901342)", 0.1195144018245045, 8.221670802315964, 17.465446543649804, ["BMPER"], 0.22334253840954277, 0, 0], [479, "positive regulation of nuclear division (GO:0051785)", 0.1195144018245045, 8.221670802315964, 17.465446543649804, ["IL1A"], 0.22334253840954277, 0, 0], [480, "positive regulation of toll-like receptor signaling pathway (GO:0034123)", 0.1195144018245045, 8.221670802315964, 17.465446543649804, ["TLR2"], 0.22334253840954277, 0, 0], [481, "positive regulation of macromolecule biosynthetic process (GO:0010557)", 0.12324291703373862, 3.3856555973981513, 7.0882015707087795, ["CCL2", "TLR2"], 0.22545014199744204, 0, 0], [482, "regulation of B cell activation (GO:0050864)", 0.1236582718648177, 7.916766228594185, 16.54788911057846, ["THEMIS2"], 0.22545014199744204, 0, 0], [483, "regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239)", 0.1236582718648177, 7.916766228594185, 16.54788911057846, ["IL1A"], 0.22545014199744204, 0, 0], [484, "cellular zinc ion homeostasis (GO:0006882)", 0.1236582718648177, 7.916766228594185, 16.54788911057846, ["MT2A"], 0.22545014199744204, 0, 0], [485, "regulation of microtubule polymerization or depolymerization (GO:0031110)", 0.1236582718648177, 7.916766228594185, 16.54788911057846, ["MAP1B"], 0.22545014199744204, 0, 0], [486, "regulation of neuron migration (GO:2001222)", 0.1236582718648177, 7.916766228594185, 16.54788911057846, ["CX3CL1"], 0.22545014199744204, 0, 0], [487, "regulation of protein transport (GO:0051223)", 0.1236582718648177, 7.916766228594185, 16.54788911057846, ["SAA1"], 0.22545014199744204, 0, 0], [488, "positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482)", 0.1236582718648177, 7.916766228594185, 16.54788911057846, ["C3AR1"], 0.22545014199744204, 0, 0], [489, "sarcomere organization (GO:0045214)", 0.1236582718648177, 7.916766228594185, 16.54788911057846, ["MYPN"], 0.22545014199744204, 0, 0], [490, "positive regulation of monooxygenase activity (GO:0032770)", 0.1236582718648177, 7.916766228594185, 16.54788911057846, ["GCH1"], 0.22545014199744204, 0, 0], [491, "T cell activation involved in immune response (GO:0002286)", 0.1236582718648177, 7.916766228594185, 16.54788911057846, ["ICAM1"], 0.22545014199744204, 0, 0], [492, "positive regulation of response to wounding (GO:1903036)", 0.1236582718648177, 7.916766228594185, 16.54788911057846, ["HBEGF"], 0.22545014199744204, 0, 0], [493, "regulation of cell migration (GO:0030334)", 0.12593143348199679, 2.1454345434543454, 4.44537834579149, ["IFITM1", "CCL5", "CX3CL1", "HBEGF"], 0.22832910930940548, 0, 0], [494, "cellular response to metal ion (GO:0071248)", 0.12636693487251843, 3.3328277721604316, 6.894172289267867, ["JUN", "MT2A"], 0.22832910930940548, 0, 0], [495, "positive regulation of dephosphorylation (GO:0035306)", 0.12778284601262158, 7.6336405529953915, 15.705627428388125, ["PPP1R16B"], 0.22832910930940548, 0, 0], [496, "response to zinc ion (GO:0010043)", 0.12778284601262158, 7.6336405529953915, 15.705627428388125, ["MT2A"], 0.22832910930940548, 0, 0], [497, "positive regulation of leukocyte migration (GO:0002687)", 0.12778284601262158, 7.6336405529953915, 15.705627428388125, ["ICAM1"], 0.22832910930940548, 0, 0], [498, "intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059)", 0.12778284601262158, 7.6336405529953915, 15.705627428388125, ["CASP4"], 0.22832910930940548, 0, 0], [499, "lamellipodium organization (GO:0097581)", 0.12778284601262158, 7.6336405529953915, 15.705627428388125, ["ARHGEF4"], 0.22832910930940548, 0, 0], [500, "positive regulation of viral genome replication (GO:0045070)", 0.12778284601262158, 7.6336405529953915, 15.705627428388125, ["CCL5"], 0.22832910930940548, 0, 0], [501, "protein ADP-ribosylation (GO:0006471)", 0.12778284601262158, 7.6336405529953915, 15.705627428388125, ["PARP10"], 0.22832910930940548, 0, 0], [502, "MyD88-dependent toll-like receptor signaling pathway (GO:0002755)", 0.12778284601262158, 7.6336405529953915, 15.705627428388125, ["TLR2"], 0.22832910930940548, 0, 0], [503, "regulation of cell adhesion (GO:0030155)", 0.12950989131689603, 3.2816130102887486, 6.707610495219723, ["CCL5", "SAA1"], 0.23061155395602184, 0, 0], [504, "negative regulation of signal transduction (GO:0009968)", 0.1310960016881068, 2.452797202797203, 4.983655625465837, ["CCL5", "CX3CL1", "TRABD2A"], 0.23061155395602184, 0, 0], [505, "alpha-amino acid catabolic process (GO:1901606)", 0.13188821313203924, 7.370040786058584, 14.930232938854378, ["KYNU"], 0.23061155395602184, 0, 0], [506, "negative regulation of cytoskeleton organization (GO:0051494)", 0.13188821313203924, 7.370040786058584, 14.930232938854378, ["SSH1"], 0.23061155395602184, 0, 0], [507, "negative regulation of interleukin-1 production (GO:0032692)", 0.13188821313203924, 7.370040786058584, 14.930232938854378, ["CX3CL1"], 0.23061155395602184, 0, 0], [508, "cardiac muscle cell action potential (GO:0086001)", 0.13188821313203924, 7.370040786058584, 14.930232938854378, ["HCN4"], 0.23061155395602184, 0, 0], [509, "regulation of striated muscle contraction (GO:0006942)", 0.13188821313203924, 7.370040786058584, 14.930232938854378, ["HCN4"], 0.23061155395602184, 0, 0], [510, "ion homeostasis (GO:0050801)", 0.13188821313203924, 7.370040786058584, 14.930232938854378, ["HCN4"], 0.23061155395602184, 0, 0], [511, "positive regulation of phosphate metabolic process (GO:0045937)", 0.13188821313203924, 7.370040786058584, 14.930232938854378, ["CCL5"], 0.23061155395602184, 0, 0], [512, "TRIF-dependent toll-like receptor signaling pathway (GO:0035666)", 0.13188821313203924, 7.370040786058584, 14.930232938854378, ["IRF7"], 0.23061155395602184, 0, 0], [513, "zinc ion homeostasis (GO:0055069)", 0.13188821313203924, 7.370040786058584, 14.930232938854378, ["MT2A"], 0.23061155395602184, 0, 0], [514, "cellular calcium ion homeostasis (GO:0006874)", 0.13425848328688705, 3.207657365347177, 6.4409386440514504, ["STC2", "CCL5"], 0.2336572646510522, 0, 0], [515, "positive regulation of transcription by RNA polymerase II (GO:0045944)", 0.13509769855017184, 1.6971564162424893, 3.3972948539534227, ["JUN", "IFI16", "IRF7", "FHL5", "CX3CL1", "TLR2", "IRF2BPL"], 0.2336572646510522, 0, 0], [516, "negative regulation of interleukin-6 production (GO:0032715)", 0.1359744617032879, 7.124014336917563, 14.21446168945804, ["CX3CL1"], 0.2336572646510522, 0, 0], [517, "cellular nitrogen compound biosynthetic process (GO:0044271)", 0.1359744617032879, 7.124014336917563, 14.21446168945804, ["GCH1"], 0.2336572646510522, 0, 0], [518, "cellular response to cAMP (GO:0071320)", 0.1359744617032879, 7.124014336917563, 14.21446168945804, ["HCN4"], 0.2336572646510522, 0, 0], [519, "peptide cross-linking (GO:0018149)", 0.1359744617032879, 7.124014336917563, 14.21446168945804, ["PI3"], 0.2336572646510522, 0, 0], [520, "positive regulation of leukocyte cell-cell adhesion (GO:1903039)", 0.1359744617032879, 7.124014336917563, 14.21446168945804, ["CCL2"], 0.2336572646510522, 0, 0], [521, "positive regulation of mononuclear cell migration (GO:0071677)", 0.1359744617032879, 7.124014336917563, 14.21446168945804, ["CCL5"], 0.2336572646510522, 0, 0], [522, "MyD88-independent toll-like receptor signaling pathway (GO:0002756)", 0.1359744617032879, 7.124014336917563, 14.21446168945804, ["IRF7"], 0.2336572646510522, 0, 0], [523, "protein dephosphorylation (GO:0006470)", 0.13904624515392036, 3.136940653760711, 6.189022991823528, ["PTPRH", "SSH1"], 0.23746197877449712, 0, 0], [524, "negative regulation of developmental growth (GO:0048640)", 0.14004167979008805, 6.893860561914672, 13.552055795836344, ["SLC6A4"], 0.23746197877449712, 0, 0], [525, "cellular response to glucose stimulus (GO:0071333)", 0.14004167979008805, 6.893860561914672, 13.552055795836344, ["PCK2"], 0.23746197877449712, 0, 0], [526, "regulation of NMDA receptor activity (GO:2000310)", 0.14004167979008805, 6.893860561914672, 13.552055795836344, ["CCL2"], 0.23746197877449712, 0, 0], [527, "ERBB2 signaling pathway (GO:0038128)", 0.14004167979008805, 6.893860561914672, 13.552055795836344, ["HBEGF"], 0.23746197877449712, 0, 0], [528, "liver development (GO:0001889)", 0.14004167979008805, 6.893860561914672, 13.552055795836344, ["PCK2"], 0.23746197877449712, 0, 0], [529, "positive regulation of receptor signaling pathway via STAT (GO:1904894)", 0.14004167979008805, 6.893860561914672, 13.552055795836344, ["CCL5"], 0.23746197877449712, 0, 0], [530, "neuron projection morphogenesis (GO:0048812)", 0.14065052279809975, 3.114051669817265, 6.108140811357775, ["MAP1B", "DCLK1"], 0.23804437537716128, 0, 0], [531, "actin filament bundle assembly (GO:0051017)", 0.14408995508930966, 6.678091397849462, 12.93758324031252, ["ADD2"], 0.24113561514013201, 0, 0], [532, "actin filament bundle organization (GO:0061572)", 0.14408995508930966, 6.678091397849462, 12.93758324031252, ["ADD2"], 0.24113561514013201, 0, 0], [533, "apoptotic mitochondrial changes (GO:0008637)", 0.14408995508930966, 6.678091397849462, 12.93758324031252, ["IFIT2"], 0.24113561514013201, 0, 0], [534, "neuron projection extension (GO:1990138)", 0.14408995508930966, 6.678091397849462, 12.93758324031252, ["MAP1B"], 0.24113561514013201, 0, 0], [535, "signal transduction by p53 class mediator (GO:0072331)", 0.14408995508930966, 6.678091397849462, 12.93758324031252, ["IFI16"], 0.24113561514013201, 0, 0], [536, "positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427)", 0.14408995508930966, 6.678091397849462, 12.93758324031252, ["CCL5"], 0.24113561514013201, 0, 0], [537, "negative regulation of cell migration (GO:0030336)", 0.14710747662405477, 3.0257195345988976, 5.799069327339981, ["IFITM1", "CX3CL1"], 0.2442336015561443, 0, 0], [538, "negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042)", 0.14811937485679208, 6.4753991528185075, 12.366307690734349, ["ICAM1"], 0.2442336015561443, 0, 0], [539, "positive regulation of calcium ion transport into cytosol (GO:0010524)", 0.14811937485679208, 6.4753991528185075, 12.366307690734349, ["CX3CL1"], 0.2442336015561443, 0, 0], [540, "positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742)", 0.14811937485679208, 6.4753991528185075, 12.366307690734349, ["HBEGF"], 0.2442336015561443, 0, 0], [541, "positive regulation of interleukin-12 production (GO:0032735)", 0.14811937485679208, 6.4753991528185075, 12.366307690734349, ["TLR2"], 0.2442336015561443, 0, 0], [542, "positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895)", 0.14811937485679208, 6.4753991528185075, 12.366307690734349, ["JUN"], 0.2442336015561443, 0, 0], [543, "positive regulation of protein dephosphorylation (GO:0035307)", 0.14811937485679208, 6.4753991528185075, 12.366307690734349, ["PPP1R16B"], 0.2442336015561443, 0, 0], [544, "positive regulation of release of sequestered calcium ion into cytosol (GO:0051281)", 0.14811937485679208, 6.4753991528185075, 12.366307690734349, ["CX3CL1"], 0.2442336015561443, 0, 0], [545, "positive regulation of programmed cell death (GO:0043068)", 0.15168857833953994, 2.2859084378519006, 4.31105344008299, ["JUN", "ARHGEF4", "IFIT2"], 0.24811024235565063, 0, 0], [546, "positive regulation of cytosolic calcium ion concentration (GO:0007204)", 0.15199003266589534, 2.9626686656671666, 5.581490998053847, ["C3AR1", "SAA1"], 0.24811024235565063, 0, 0], [547, "negative regulation of cell cycle G1/S phase transition (GO:1902807)", 0.15213002597057732, 6.2846299810246675, 11.834081997339505, ["CCL2"], 0.24811024235565063, 0, 0], [548, "cellular response to virus (GO:0098586)", 0.15213002597057732, 6.2846299810246675, 11.834081997339505, ["CCL5"], 0.24811024235565063, 0, 0], [549, "regulation of trans-synaptic signaling (GO:0099177)", 0.15213002597057732, 6.2846299810246675, 11.834081997339505, ["GRID1"], 0.24811024235565063, 0, 0], [550, "positive regulation of lymphocyte activation (GO:0051251)", 0.15213002597057732, 6.2846299810246675, 11.834081997339505, ["CCL2"], 0.24811024235565063, 0, 0], [551, "regulation of cytosolic calcium ion concentration (GO:0051480)", 0.15362476689662452, 2.942227516378797, 5.511504829388989, ["C3AR1", "SAA1"], 0.25009331380448674, 0, 0], [552, "regulation of cardiac muscle contraction (GO:0055117)", 0.15612199492849957, 6.104761904761904, 11.33726052426851, ["HCN4"], 0.2514208787268656, 0, 0], [553, "cellular response to heat (GO:0034605)", 0.15612199492849957, 6.104761904761904, 11.33726052426851, ["IL1A"], 0.2514208787268656, 0, 0], [554, "regulation of sodium ion transport (GO:0002028)", 0.15612199492849957, 6.104761904761904, 11.33726052426851, ["NKAIN1"], 0.2514208787268656, 0, 0], [555, "positive regulation of cytokine-mediated signaling pathway (GO:0001961)", 0.15612199492849957, 6.104761904761904, 11.33726052426851, ["CASP4"], 0.2514208787268656, 0, 0], [556, "positive regulation of mitotic nuclear division (GO:0045840)", 0.15612199492849957, 6.104761904761904, 11.33726052426851, ["IL1A"], 0.2514208787268656, 0, 0], [557, "intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)", 0.15612199492849957, 6.104761904761904, 11.33726052426851, ["IFI16"], 0.2514208787268656, 0, 0], [558, "negative regulation of endothelial cell proliferation (GO:0001937)", 0.16009536782343659, 5.934886499402628, 10.872626559544205, ["CCL2"], 0.2555258806719264, 0, 0], [559, "negative regulation of epithelial cell apoptotic process (GO:1904036)", 0.16009536782343659, 5.934886499402628, 10.872626559544205, ["ICAM1"], 0.2555258806719264, 0, 0], [560, "negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)", 0.16009536782343659, 5.934886499402628, 10.872626559544205, ["CCL2"], 0.2555258806719264, 0, 0], [561, "neural crest cell migration (GO:0001755)", 0.16009536782343659, 5.934886499402628, 10.872626559544205, ["NRTN"], 0.2555258806719264, 0, 0], [562, "regulation of vascular associated smooth muscle cell proliferation (GO:1904705)", 0.16009536782343659, 5.934886499402628, 10.872626559544205, ["JUN"], 0.2555258806719264, 0, 0], [563, "dephosphorylation (GO:0016311)", 0.16184948811187044, 2.8440829254247046, 5.179326598603839, ["PTPRH", "SSH1"], 0.25786676880345966, 0, 0], [564, "regulation of apoptotic signaling pathway (GO:2001233)", 0.16405023032390117, 5.774193548387097, 10.437331877116597, ["CX3CL1"], 0.2604478877885652, 0, 0], [565, "response to cAMP (GO:0051591)", 0.16405023032390117, 5.774193548387097, 10.437331877116597, ["HCN4"], 0.2604478877885652, 0, 0], [566, "positive regulation of NF-kappaB transcription factor activity (GO:0051092)", 0.1651619558469531, 2.8066211992043195, 5.054244106312554, ["CX3CL1", "TLR2"], 0.2617496014040935, 0, 0], [567, "regulation of cellular component biogenesis (GO:0044087)", 0.16798666774760343, 5.621958121109225, 10.02884615171532, ["PARP10"], 0.26389499294150665, 0, 0], [568, "cellular response to ketone (GO:1901655)", 0.16798666774760343, 5.621958121109225, 10.02884615171532, ["PCK2"], 0.26389499294150665, 0, 0], [569, "regulation of heart rate by cardiac conduction (GO:0086091)", 0.16798666774760343, 5.621958121109225, 10.02884615171532, ["HCN4"], 0.26389499294150665, 0, 0], [570, "organophosphate biosynthetic process (GO:0090407)", 0.16798666774760343, 5.621958121109225, 10.02884615171532, ["MOCOS"], 0.26389499294150665, 0, 0], [571, "regulation of viral entry into host cell (GO:0046596)", 0.16798666774760343, 5.621958121109225, 10.02884615171532, ["IFITM1"], 0.26389499294150665, 0, 0], [572, "cellular response to growth factor stimulus (GO:0071363)", 0.17015322020880044, 2.7522296544035676, 4.874352712102551, ["CCL5", "CCL2"], 0.2663655122640384, 0, 0], [573, "organonitrogen compound biosynthetic process (GO:1901566)", 0.17015322020880044, 2.7522296544035676, 4.874352712102551, ["GCH1", "MOCOS"], 0.2663655122640384, 0, 0], [574, "negative regulation of cell-substrate adhesion (GO:0010812)", 0.17190476501211555, 5.477529638819961, 9.64491441906839, ["CX3CL1"], 0.266779540165861, 0, 0], [575, "negative regulation of ERBB signaling pathway (GO:1901185)", 0.17190476501211555, 5.477529638819961, 9.64491441906839, ["HBEGF"], 0.266779540165861, 0, 0], [576, "positive regulation of cation channel activity (GO:2001259)", 0.17190476501211555, 5.477529638819961, 9.64491441906839, ["CCL2"], 0.266779540165861, 0, 0], [577, "response to organonitrogen compound (GO:0010243)", 0.17190476501211555, 5.477529638819961, 9.64491441906839, ["KYNU"], 0.266779540165861, 0, 0], [578, "positive regulation of wound healing (GO:0090303)", 0.17190476501211555, 5.477529638819961, 9.64491441906839, ["HBEGF"], 0.266779540165861, 0, 0], [579, "positive regulation of protein kinase B signaling (GO:0051897)", 0.17517003696225372, 2.699890620727372, 4.703204431439755, ["CX3CL1", "HBEGF"], 0.2704918219386568, 0, 0], [580, "regulation of cell development (GO:0060284)", 0.17580460667807904, 5.340322580645161, 9.283521128961365, ["CX3CL1"], 0.2704918219386568, 0, 0], [581, "regulation of filopodium assembly (GO:0051489)", 0.17580460667807904, 5.340322580645161, 9.283521128961365, ["PPP1R16B"], 0.2704918219386568, 0, 0], [582, "regulation of protein dephosphorylation (GO:0035304)", 0.17580460667807904, 5.340322580645161, 9.283521128961365, ["PPP1R16B"], 0.2704918219386568, 0, 0], [583, "gluconeogenesis (GO:0006094)", 0.17580460667807904, 5.340322580645161, 9.283521128961365, ["PCK2"], 0.2704918219386568, 0, 0], [584, "positive regulation of apoptotic process (GO:0043065)", 0.17905198881233722, 2.104628270752049, 3.620127049213206, ["JUN", "ARHGEF4", "IFIT2"], 0.27318405143087304, 0, 0], [585, "regulation of chemokine production (GO:0032642)", 0.1796862768608864, 5.2098085496984, 8.942859642156431, ["TLR2"], 0.27318405143087304, 0, 0], [586, "regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041)", 0.1796862768608864, 5.2098085496984, 8.942859642156431, ["ICAM1"], 0.27318405143087304, 0, 0], [587, "regulation of nervous system development (GO:0051960)", 0.1796862768608864, 5.2098085496984, 8.942859642156431, ["CX3CL1"], 0.27318405143087304, 0, 0], [588, "heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157)", 0.1796862768608864, 5.2098085496984, 8.942859642156431, ["ICAM1"], 0.27318405143087304, 0, 0], [589, "positive regulation of protein tyrosine kinase activity (GO:0061098)", 0.1796862768608864, 5.2098085496984, 8.942859642156431, ["HBEGF"], 0.27318405143087304, 0, 0], [590, "potassium ion import across plasma membrane (GO:1990573)", 0.1796862768608864, 5.2098085496984, 8.942859642156431, ["HCN4"], 0.27318405143087304, 0, 0], [591, "regulation of cell-substrate adhesion (GO:0010810)", 0.18354985931171927, 5.085509472606247, 8.621306230224262, ["CX3CL1"], 0.27717882795052556, 0, 0], [592, "cellular glucose homeostasis (GO:0001678)", 0.18354985931171927, 5.085509472606247, 8.621306230224262, ["PCK2"], 0.27717882795052556, 0, 0], [593, "cellular response to glucose starvation (GO:0042149)", 0.18354985931171927, 5.085509472606247, 8.621306230224262, ["IFI16"], 0.27717882795052556, 0, 0], [594, "myofibril assembly (GO:0030239)", 0.18354985931171927, 5.085509472606247, 8.621306230224262, ["MYPN"], 0.27717882795052556, 0, 0], [595, "positive regulation of cell population proliferation (GO:0008284)", 0.1839045974886488, 1.837919621749409, 3.1122194079993197, ["CCL5", "CX3CL1", "CXCL5", "HBEGF"], 0.2772477713400302, 0, 0], [596, "antibacterial humoral response (GO:0019731)", 0.18739543746322412, 4.9669917479369845, 8.317397831132554, ["PI3"], 0.27922542758224594, 0, 0], [597, "negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059)", 0.18739543746322412, 4.9669917479369845, 8.317397831132554, ["HBEGF"], 0.27922542758224594, 0, 0], [598, "positive regulation of biosynthetic process (GO:0009891)", 0.18739543746322412, 4.9669917479369845, 8.317397831132554, ["CCL5"], 0.27922542758224594, 0, 0], [599, "positive regulation of cell-matrix adhesion (GO:0001954)", 0.18739543746322412, 4.9669917479369845, 8.317397831132554, ["CX3CL1"], 0.27922542758224594, 0, 0], [600, "hexose biosynthetic process (GO:0019319)", 0.18739543746322412, 4.9669917479369845, 8.317397831132554, ["PCK2"], 0.27922542758224594, 0, 0], [601, "positive regulation of osteoblast differentiation (GO:0045669)", 0.18739543746322412, 4.9669917479369845, 8.317397831132554, ["IFITM1"], 0.27922542758224594, 0, 0], [602, "metal ion homeostasis (GO:0055065)", 0.18739543746322412, 4.9669917479369845, 8.317397831132554, ["CLDN16"], 0.27922542758224594, 0, 0], [603, "cellular response to radiation (GO:0071478)", 0.1912230942444782, 4.85386119257087, 8.029812951184406, ["IFI16"], 0.28258173894118116, 0, 0], [604, "neural crest cell development (GO:0014032)", 0.1912230942444782, 4.85386119257087, 8.029812951184406, ["NRTN"], 0.28258173894118116, 0, 0], [605, "regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893)", 0.1912230942444782, 4.85386119257087, 8.029812951184406, ["JUN"], 0.28258173894118116, 0, 0], [606, "regulation of receptor signaling pathway via JAK-STAT (GO:0046425)", 0.1912230942444782, 4.85386119257087, 8.029812951184406, ["CCL5"], 0.28258173894118116, 0, 0], [607, "zymogen activation (GO:0031638)", 0.1912230942444782, 4.85386119257087, 8.029812951184406, ["IFI16"], 0.28258173894118116, 0, 0], [608, "neuron projection development (GO:0031175)", 0.19205610339746856, 2.538847440185233, 4.189016384366881, ["NRTN", "DCLK1"], 0.2833459288610679, 0, 0], [609, "regulation of fibroblast proliferation (GO:0048145)", 0.19503291231959316, 4.745758661887694, 7.757355193343563, ["PARP10"], 0.2863249138308921, 0, 0], [610, "negative regulation of tumor necrosis factor production (GO:0032720)", 0.19503291231959316, 4.745758661887694, 7.757355193343563, ["CX3CL1"], 0.2863249138308921, 0, 0], [611, "regulation of synaptic transmission, glutamatergic (GO:0051966)", 0.19503291231959316, 4.745758661887694, 7.757355193343563, ["CCL2"], 0.2863249138308921, 0, 0], [612, "regulation of cellular metabolic process (GO:0031323)", 0.1988249739405069, 4.642356241234221, 7.498939021140666, ["SSH1"], 0.2899934985766418, 0, 0], [613, "epidermal growth factor receptor signaling pathway (GO:0007173)", 0.1988249739405069, 4.642356241234221, 7.498939021140666, ["HBEGF"], 0.2899934985766418, 0, 0], [614, "regulation of synapse assembly (GO:0051963)", 0.1988249739405069, 4.642356241234221, 7.498939021140666, ["TLR2"], 0.2899934985766418, 0, 0], [615, "regulation of wound healing (GO:0061041)", 0.1988249739405069, 4.642356241234221, 7.498939021140666, ["HBEGF"], 0.2899934985766418, 0, 0], [616, "cellular response to ionizing radiation (GO:0071479)", 0.20259936093805347, 4.54335392358728, 7.253577402625964, ["IFI16"], 0.29358905777291433, 0, 0], [617, "negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556)", 0.20259936093805347, 4.54335392358728, 7.253577402625964, ["CX3CL1"], 0.29358905777291433, 0, 0], [618, "regulation of interleukin-2 production (GO:0032663)", 0.20259936093805347, 4.54335392358728, 7.253577402625964, ["IL1A"], 0.29358905777291433, 0, 0], [619, "regulation of protein metabolic process (GO:0051246)", 0.20259936093805347, 4.54335392358728, 7.253577402625964, ["SSH1"], 0.29358905777291433, 0, 0], [620, "regulation of cellular protein metabolic process (GO:0032268)", 0.20635615488224898, 4.448476702508961, 7.0203710519550615, ["SSH1"], 0.29759078927552624, 0, 0], [621, "cellular defense response (GO:0006968)", 0.20635615488224898, 4.448476702508961, 7.0203710519550615, ["ADORA2A"], 0.29759078927552624, 0, 0], [622, "response to glucose (GO:0009749)", 0.20635615488224898, 4.448476702508961, 7.0203710519550615, ["PCK2"], 0.29759078927552624, 0, 0], [623, "regulation of cellular component movement (GO:0051270)", 0.2100954368002021, 4.357472021066491, 6.79849904676328, ["HBEGF"], 0.30152897089565006, 0, 0], [624, "neuron migration (GO:0001764)", 0.2100954368002021, 4.357472021066491, 6.79849904676328, ["MAP1B"], 0.30152897089565006, 0, 0], [625, "positive regulation of ion transport (GO:0043270)", 0.2100954368002021, 4.357472021066491, 6.79849904676328, ["CCL5"], 0.30152897089565006, 0, 0], [626, "regulation of epithelial cell migration (GO:0010632)", 0.21381728752060247, 4.270107526881721, 6.5872106005284925, ["BMPER"], 0.3034716881423741, 0, 0], [627, "negative regulation of transport (GO:0051051)", 0.21381728752060247, 4.270107526881721, 6.5872106005284925, ["TLR2"], 0.3034716881423741, 0, 0], [628, "regulation of interleukin-12 production (GO:0032655)", 0.21381728752060247, 4.270107526881721, 6.5872106005284925, ["TLR2"], 0.3034716881423741, 0, 0], [629, "cholesterol transport (GO:0030301)", 0.21381728752060247, 4.270107526881721, 6.5872106005284925, ["STX12"], 0.3034716881423741, 0, 0], [630, "regulation of protein modification process (GO:0031399)", 0.21381728752060247, 4.270107526881721, 6.5872106005284925, ["PPP1R16B"], 0.3034716881423741, 0, 0], [631, "positive regulation of actin filament bundle assembly (GO:0032233)", 0.21381728752060247, 4.270107526881721, 6.5872106005284925, ["CX3CL1"], 0.3034716881423741, 0, 0], [632, "intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)", 0.21381728752060247, 4.270107526881721, 6.5872106005284925, ["IFI16"], 0.3034716881423741, 0, 0], [633, "negative regulation of BMP signaling pathway (GO:0030514)", 0.21752178743004932, 4.186169091292431, 6.385817851499537, ["BMPER"], 0.3063061904627225, 0, 0], [634, "ameboidal-type cell migration (GO:0001667)", 0.21752178743004932, 4.186169091292431, 6.385817851499537, ["NRTN"], 0.3063061904627225, 0, 0], [635, "plasma membrane bounded cell projection morphogenesis (GO:0120039)", 0.21752178743004932, 4.186169091292431, 6.385817851499537, ["DCLK1"], 0.3063061904627225, 0, 0], [636, "regulation of release of sequestered calcium ion into cytosol (GO:0051279)", 0.21752178743004932, 4.186169091292431, 6.385817851499537, ["CX3CL1"], 0.3063061904627225, 0, 0], [637, "myeloid cell differentiation (GO:0030099)", 0.21752178743004932, 4.186169091292431, 6.385817851499537, ["IFI16"], 0.3063061904627225, 0, 0], [638, "negative regulation of transcription by RNA polymerase II (GO:0000122)", 0.2191947408703407, 1.5908225910542602, 2.414542123711789, ["JUN", "IFI16", "IRF7", "ZNF239", "IRF2BPL"], 0.3081781858318113, 0, 0], [639, "negative regulation of cysteine-type endopeptidase activity (GO:2000117)", 0.22120901649506144, 4.10545905707196, 6.193689510005753, ["IFI16"], 0.30859173840757403, 0, 0], [640, "bicellular tight junction assembly (GO:0070830)", 0.22120901649506144, 4.10545905707196, 6.193689510005753, ["CLDN16"], 0.30859173840757403, 0, 0], [641, "cardiac muscle tissue development (GO:0048738)", 0.22120901649506144, 4.10545905707196, 6.193689510005753, ["HCN4"], 0.30859173840757403, 0, 0], [642, "positive regulation of chemokine production (GO:0032722)", 0.22120901649506144, 4.10545905707196, 6.193689510005753, ["TLR2"], 0.30859173840757403, 0, 0], [643, "positive regulation of phagocytosis (GO:0050766)", 0.22120901649506144, 4.10545905707196, 6.193689510005753, ["CCL2"], 0.30859173840757403, 0, 0], [644, "regulation of cyclin-dependent protein kinase activity (GO:1904029)", 0.22487905441669934, 4.027794684520186, 6.010245250282423, ["HERC5"], 0.3127387780027586, 0, 0], [645, "positive regulation of leukocyte chemotaxis (GO:0002690)", 0.22487905441669934, 4.027794684520186, 6.010245250282423, ["CCL5"], 0.3127387780027586, 0, 0], [646, "negative regulation of Wnt signaling pathway (GO:0030178)", 0.22639477153771126, 2.267885898320681, 3.3688878656654544, ["IGFBP1", "TRABD2A"], 0.3143593035128901, 0, 0], [647, "pyruvate metabolic process (GO:0006090)", 0.2285319804611705, 3.953006770211071, 5.8349507554646145, ["PCK2"], 0.3168364551370478, 0, 0], [648, "negative regulation of macromolecule metabolic process (GO:0010605)", 0.23159075601947499, 2.232110507246377, 3.265094303303301, ["PARP10", "STC2"], 0.31940886902735033, 0, 0], [649, "autophagosome organization (GO:1905037)", 0.23216787358509747, 3.8809384164222873, 5.667313319073533, ["STX12"], 0.31940886902735033, 0, 0], [650, "blood vessel morphogenesis (GO:0048514)", 0.23216787358509747, 3.8809384164222873, 5.667313319073533, ["CCBE1"], 0.31940886902735033, 0, 0], [651, "positive regulation of interleukin-1 beta production (GO:0032731)", 0.23216787358509747, 3.8809384164222873, 5.667313319073533, ["IFI16"], 0.31940886902735033, 0, 0], [652, "tight junction assembly (GO:0120192)", 0.23216787358509747, 3.8809384164222873, 5.667313319073533, ["CLDN16"], 0.31940886902735033, 0, 0], [653, "regulation of mitotic nuclear division (GO:0007088)", 0.23578681236015492, 3.8114439324116742, 5.506877939789336, ["IL1A"], 0.3229019399802427, 0, 0], [654, "positive regulation of interferon-gamma production (GO:0032729)", 0.23578681236015492, 3.8114439324116742, 5.506877939789336, ["EBI3"], 0.3229019399802427, 0, 0], [655, "positive regulation of proteolysis (GO:0045862)", 0.23578681236015492, 3.8114439324116742, 5.506877939789336, ["CCBE1"], 0.3229019399802427, 0, 0], [656, "regulation of signal transduction (GO:0009966)", 0.2385309524036545, 2.1861135758651287, 3.1332608312751975, ["IGFBP1", "CX3CL1"], 0.3238790661508282, 0, 0], [657, "autophagosome assembly (GO:0000045)", 0.2393888749810469, 3.7443878513488023, 5.353223842224764, ["STX12"], 0.3238790661508282, 0, 0], [658, "regulation of calcium ion transport (GO:0051924)", 0.2393888749810469, 3.7443878513488023, 5.353223842224764, ["CCL5"], 0.3238790661508282, 0, 0], [659, "regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393)", 0.2393888749810469, 3.7443878513488023, 5.353223842224764, ["BMPER"], 0.3238790661508282, 0, 0], [660, "regulation of phagocytosis (GO:0050764)", 0.2393888749810469, 3.7443878513488023, 5.353223842224764, ["TLR2"], 0.3238790661508282, 0, 0], [661, "regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803)", 0.2393888749810469, 3.7443878513488023, 5.353223842224764, ["CASP4"], 0.3238790661508282, 0, 0], [662, "positive regulation of protein binding (GO:0032092)", 0.2393888749810469, 3.7443878513488023, 5.353223842224764, ["ADD2"], 0.3238790661508282, 0, 0], [663, "muscle organ development (GO:0007517)", 0.2393888749810469, 3.7443878513488023, 5.353223842224764, ["HBEGF"], 0.3238790661508282, 0, 0], [664, "regulation of secretion by cell (GO:1903530)", 0.2429741392807045, 3.6796440489432705, 5.20596137193734, ["SAA1"], 0.32724895335554344, 0, 0], [665, "response to reactive oxygen species (GO:0000302)", 0.2429741392807045, 3.6796440489432705, 5.20596137193734, ["JUN"], 0.32724895335554344, 0, 0], [666, "positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)", 0.2429741392807045, 3.6796440489432705, 5.20596137193734, ["CCL5"], 0.32724895335554344, 0, 0], [667, "generation of neurons (GO:0048699)", 0.24548245095445353, 2.1419565217391305, 3.0084418018782744, ["MAP1B", "CX3CL1"], 0.3301315719732306, 0, 0], [668, "apical junction assembly (GO:0043297)", 0.24654268283202227, 3.617094951704028, 5.064729217695601, ["CLDN16"], 0.3305661980572855, 0, 0], [669, "homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)", 0.24654268283202227, 3.617094951704028, 5.064729217695601, ["MYPN"], 0.3305661980572855, 0, 0], [670, "axon guidance (GO:0007411)", 0.24722176040188887, 2.1311918667531904, 2.9782756958536605, ["NRTN", "MYPN"], 0.33098196877685715, 0, 0], [671, "regulation of DNA-templated transcription, initiation (GO:2000142)", 0.25009458269587825, 3.55663082437276, 4.929191927960233, ["JUN"], 0.3333355730731096, 0, 0], [672, "pattern recognition receptor signaling pathway (GO:0002221)", 0.25009458269587825, 3.55663082437276, 4.929191927960233, ["TLR2"], 0.3333355730731096, 0, 0], [673, "positive regulation of interleukin-8 production (GO:0032757)", 0.25009458269587825, 3.55663082437276, 4.929191927960233, ["TLR2"], 0.3333355730731096, 0, 0], [674, "regulation of neurogenesis (GO:0050767)", 0.25362991570207016, 3.498149127445796, 4.799037674007423, ["CX3CL1"], 0.3360502723556233, 0, 0], [675, "positive regulation of cysteine-type endopeptidase activity (GO:2001056)", 0.25362991570207016, 3.498149127445796, 4.799037674007423, ["IFI16"], 0.3360502723556233, 0, 0], [676, "glucose metabolic process (GO:0006006)", 0.25362991570207016, 3.498149127445796, 4.799037674007423, ["PCK2"], 0.3360502723556233, 0, 0], [677, "I-kappaB kinase/NF-kappaB signaling (GO:0007249)", 0.25362991570207016, 3.498149127445796, 4.799037674007423, ["TLR2"], 0.3360502723556233, 0, 0], [678, "regulation of protein kinase B signaling (GO:0051896)", 0.254183450743422, 2.089183457051962, 2.8615525455012563, ["CX3CL1", "HBEGF"], 0.33628695474461584, 0, 0], [679, "negative regulation of endopeptidase activity (GO:0010951)", 0.25714875832310913, 3.4415539368713146, 4.673976244211671, ["IFI16"], 0.3387113600819808, 0, 0], [680, "cellular response to reactive oxygen species (GO:0034614)", 0.25714875832310913, 3.4415539368713146, 4.673976244211671, ["JUN"], 0.3387113600819808, 0, 0], [681, "positive regulation of viral process (GO:0048524)", 0.25714875832310913, 3.4415539368713146, 4.673976244211671, ["CCL5"], 0.3387113600819808, 0, 0], [682, "negative regulation of inflammatory response (GO:0050728)", 0.2628924647535815, 2.0389233954451345, 2.724022473074679, ["ADORA2A", "SAA1"], 0.34576912153073697, 0, 0], [683, "regulation of cell-matrix adhesion (GO:0001952)", 0.26413727632273526, 3.3336693548387095, 4.438068423870862, ["CX3CL1"], 0.3458848713306475, 0, 0], [684, "regulation of cellular catabolic process (GO:0031329)", 0.26413727632273526, 3.3336693548387095, 4.438068423870862, ["IFI16"], 0.3458848713306475, 0, 0], [685, "G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)", 0.26413727632273526, 3.3336693548387095, 4.438068423870862, ["CCL2"], 0.3458848713306475, 0, 0], [686, "positive regulation of protein modification process (GO:0031401)", 0.266377179195435, 2.0194831829368334, 2.6714571881639757, ["PPP1R16B", "TRABD2A"], 0.34830951856895803, 0, 0], [687, "ERBB signaling pathway (GO:0038127)", 0.26760710286975803, 3.2822167080231597, 4.326734281963286, ["HBEGF"], 0.3494084006902081, 0, 0], [688, "positive regulation of macromolecule metabolic process (GO:0010604)", 0.2700079207141092, 1.689452280003461, 2.2120066017227993, ["IL1A", "FOXD1", "TLR2"], 0.3515876533785017, 0, 0], [689, "regulation of apoptotic process (GO:0042981)", 0.27006008158058825, 1.46120775082707, 1.9128828774105135, ["JUN", "ARHGEF4", "CX3CL1", "IFIT3", "IFIT2"], 0.3515876533785017, 0, 0], [690, "protein N-linked glycosylation (GO:0006487)", 0.2710607413291997, 3.2323232323232323, 4.219514652028844, ["GFPT2"], 0.3518690086429698, 0, 0], [691, "regulation of epidermal growth factor receptor signaling pathway (GO:0042058)", 0.2710607413291997, 3.2323232323232323, 4.219514652028844, ["HBEGF"], 0.3518690086429698, 0, 0], [692, "regulation of translational initiation (GO:0006446)", 0.2744982663755415, 3.1839191141068848, 4.116203532141284, ["CCL5"], 0.35530295084972685, 0, 0], [693, "regulation of tyrosine phosphorylation of STAT protein (GO:0042509)", 0.2744982663755415, 3.1839191141068848, 4.116203532141284, ["CCL5"], 0.35530295084972685, 0, 0], [694, "positive regulation of protein transport (GO:0051222)", 0.2779197524110875, 3.1369386464263123, 4.016607976369818, ["IL1A"], 0.3592132822950223, 0, 0], [695, "positive regulation of cell motility (GO:2000147)", 0.278572962825871, 1.9542386341076037, 2.497664067810718, ["CCL5", "HBEGF"], 0.3595394930284983, 0, 0], [696, "regulation of plasma membrane bounded cell projection assembly (GO:0120032)", 0.28132527343488767, 3.0913199314321336, 3.920547096946552, ["PPP1R16B"], 0.362049885611326, 0, 0], [697, "positive regulation of cell-substrate adhesion (GO:0010811)", 0.28132527343488767, 3.0913199314321336, 3.920547096946552, ["CX3CL1"], 0.362049885611326, 0, 0], [698, "regulation of G1/S transition of mitotic cell cycle (GO:2000045)", 0.2847149032181373, 3.0470046082949307, 3.8278511522978844, ["CCL2"], 0.36536375992370407, 0, 0], [699, "myeloid leukocyte differentiation (GO:0002573)", 0.2847149032181373, 3.0470046082949307, 3.8278511522978844, ["IFI16"], 0.36536375992370407, 0, 0], [700, "negative regulation of transcription, DNA-templated (GO:0045892)", 0.28695028388026267, 1.372611464968153, 1.713631711813169, ["JUN", "FOXD1", "IFI16", "IRF7", "ZNF239", "IRF2BPL"], 0.36654691826631147, 0, 0], [701, "cell junction organization (GO:0034330)", 0.2880887150253619, 3.0039376041193395, 3.738360720374842, ["FBLIM1"], 0.36654691826631147, 0, 0], [702, "negative regulation of supramolecular fiber organization (GO:1902904)", 0.2880887150253619, 3.0039376041193395, 3.738360720374842, ["SSH1"], 0.36654691826631147, 0, 0], [703, "response to ionizing radiation (GO:0010212)", 0.2880887150253619, 3.0039376041193395, 3.738360720374842, ["IFI16"], 0.36654691826631147, 0, 0], [704, "positive regulation of neurogenesis (GO:0050769)", 0.2880887150253619, 3.0039376041193395, 3.738360720374842, ["CX3CL1"], 0.36654691826631147, 0, 0], [705, "positive regulation of secretion by cell (GO:1903532)", 0.2880887150253619, 3.0039376041193395, 3.738360720374842, ["IL1A"], 0.36654691826631147, 0, 0], [706, "negative regulation of cell adhesion (GO:0007162)", 0.2914467819279733, 2.9620669056152926, 3.6519259376872046, ["CX3CL1"], 0.3676902438669368, 0, 0], [707, "regulation of actin filament polymerization (GO:0030833)", 0.2914467819279733, 2.9620669056152926, 3.6519259376872046, ["SSH1"], 0.3676902438669368, 0, 0], [708, "neurotransmitter transport (GO:0006836)", 0.2914467819279733, 2.9620669056152926, 3.6519259376872046, ["SLC6A4"], 0.3676902438669368, 0, 0], [709, "endoplasmic reticulum organization (GO:0007029)", 0.2914467819279733, 2.9620669056152926, 3.6519259376872046, ["REEP2"], 0.3676902438669368, 0, 0], [710, "response to molecule of bacterial origin (GO:0002237)", 0.2914467819279733, 2.9620669056152926, 3.6519259376872046, ["GCH1"], 0.3676902438669368, 0, 0], [711, "positive regulation of synaptic transmission (GO:0050806)", 0.2914467819279733, 2.9620669056152926, 3.6519259376872046, ["CCL2"], 0.3676902438669368, 0, 0], [712, "negative regulation of protein binding (GO:0032091)", 0.29478917666716925, 2.921343349536014, 3.5684058083253287, ["IFIT2"], 0.37086380290385806, 0, 0], [713, "regulation of peptide hormone secretion (GO:0090276)", 0.29478917666716925, 2.921343349536014, 3.5684058083253287, ["CCL5"], 0.37086380290385806, 0, 0], [714, "positive regulation of lymphocyte proliferation (GO:0050671)", 0.298115971484896, 2.881720430107527, 3.4876675717165058, ["CCL5"], 0.3745238465293441, 0, 0], [715, "cell morphogenesis involved in neuron differentiation (GO:0048667)", 0.30142723851230935, 2.8431541218637992, 3.4095861178637743, ["MAP1B"], 0.3776260236669574, 0, 0], [716, "regulation of T cell proliferation (GO:0042129)", 0.30142723851230935, 2.8431541218637992, 3.4095861178637743, ["CCL5"], 0.3776260236669574, 0, 0], [717, "positive regulation of endothelial cell proliferation (GO:0001938)", 0.3047230494687358, 2.805602716468591, 3.334043457403817, ["PPP1R16B"], 0.38016213542900695, 0, 0], [718, "inorganic cation import across plasma membrane (GO:0098659)", 0.3047230494687358, 2.805602716468591, 3.334043457403817, ["HCN4"], 0.38016213542900695, 0, 0], [719, "positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)", 0.3047230494687358, 2.805602716468591, 3.334043457403817, ["CCL5"], 0.38016213542900695, 0, 0], [720, "negative regulation of apoptotic signaling pathway (GO:2001234)", 0.30800347559160407, 2.769026672252479, 3.2609282325764797, ["CX3CL1"], 0.38318879002173206, 0, 0], [721, "protein modification process (GO:0036211)", 0.30800347559160407, 2.769026672252479, 3.2609282325764797, ["UBE2L6"], 0.38318879002173206, 0, 0], [722, "axon development (GO:0061564)", 0.3112685880435018, 2.733388475323959, 3.1901352632985813, ["MAP1B"], 0.3856463031422944, 0, 0], [723, "negative regulation of NF-kappaB transcription factor activity (GO:0032088)", 0.3112685880435018, 2.733388475323959, 3.1901352632985813, ["PARP10"], 0.3856463031422944, 0, 0], [724, "regulation of ion transport (GO:0043269)", 0.3112685880435018, 2.733388475323959, 3.1901352632985813, ["NKAIN1"], 0.3856463031422944, 0, 0], [725, "negative regulation of cellular response to growth factor stimulus (GO:0090288)", 0.31451845750569757, 2.698652511229073, 3.121565136481931, ["BMPER"], 0.3891352501829113, 0, 0], [726, "activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)", 0.31775315442454277, 2.664784946236559, 3.0551238218857484, ["CASP4"], 0.3909802188186761, 0, 0], [727, "negative regulation of protein modification process (GO:0031400)", 0.31775315442454277, 2.664784946236559, 3.0551238218857484, ["PPP1R16B"], 0.3909802188186761, 0, 0], [728, "regulation of interleukin-8 production (GO:0032677)", 0.31775315442454277, 2.664784946236559, 3.0551238218857484, ["TLR2"], 0.3909802188186761, 0, 0], [729, "phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200)", 0.31775315442454277, 2.664784946236559, 3.0551238218857484, ["C3AR1"], 0.3909802188186761, 0, 0], [730, "regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)", 0.320972748763277, 2.6317536174166998, 2.9907223219154155, ["HERC5"], 0.39232882056945817, 0, 0], [731, "regulation of G protein-coupled receptor signaling pathway (GO:0008277)", 0.320972748763277, 2.6317536174166998, 2.9907223219154155, ["CCL5"], 0.39232882056945817, 0, 0], [732, "regulation of gene expression, epigenetic (GO:0040029)", 0.320972748763277, 2.6317536174166998, 2.9907223219154155, ["IFI16"], 0.39232882056945817, 0, 0], [733, "positive regulation of cytoskeleton organization (GO:0051495)", 0.320972748763277, 2.6317536174166998, 2.9907223219154155, ["CX3CL1"], 0.39232882056945817, 0, 0], [734, "positive regulation of transcription, DNA-templated (GO:0045893)", 0.32103606945148533, 1.281472359058566, 1.4560111962355387, ["JUN", "IFI16", "IRF7", "FHL5", "CX3CL1", "TLR2", "IRF2BPL"], 0.39232882056945817, 0, 0], [735, "positive regulation of DNA-binding transcription factor activity (GO:0051091)", 0.32195932759478924, 1.7517818959372773, 1.9853470693754856, ["CX3CL1", "TLR2"], 0.3929217916360897, 0, 0], [736, "regulation of osteoblast differentiation (GO:0045667)", 0.32417731041945197, 2.5995279307631787, 2.9282763427827727, ["IFITM1"], 0.3950910970737071, 0, 0], [737, "response to insulin (GO:0032868)", 0.32736690873650537, 2.568078766679622, 2.867705997840743, ["PCK2"], 0.3984370653143084, 0, 0], [738, "positive regulation of signal transduction (GO:0009967)", 0.33229449742681816, 1.7092173913043478, 1.8831023370625135, ["CCBE1", "TLR2"], 0.40388640134397813, 0, 0], [739, "regulation of interferon-gamma production (GO:0032649)", 0.33370149159207996, 2.5074003795066413, 2.7518930372832235, ["EBI3"], 0.4045003215649942, 0, 0], [740, "regulation of neuron death (GO:1901214)", 0.33370149159207996, 2.5074003795066413, 2.7518930372832235, ["CCL5"], 0.4045003215649942, 0, 0], [741, "positive regulation of neuron projection development (GO:0010976)", 0.3399770465510176, 2.449511803238166, 2.6427223714548616, ["CX3CL1"], 0.4109965104531844, 0, 0], [742, "metal ion transport (GO:0030001)", 0.3399770465510176, 2.449511803238166, 2.6427223714548616, ["CCL5"], 0.4109965104531844, 0, 0], [743, "regulation of endothelial cell migration (GO:0010594)", 0.3430928588581939, 2.4215542521994133, 2.590467693599858, ["BMPER"], 0.413648245155645, 0, 0], [744, "transforming growth factor beta receptor signaling pathway (GO:0007179)", 0.3430928588581939, 2.4215542521994133, 2.590467693599858, ["JUN"], 0.413648245155645, 0, 0], [745, "cellular amino acid catabolic process (GO:0009063)", 0.34619411785401744, 2.3942249607345656, 2.5396875993674386, ["KYNU"], 0.4157110089893623, 0, 0], [746, "positive regulation of binding (GO:0051099)", 0.34619411785401744, 2.3942249607345656, 2.5396875993674386, ["ADD2"], 0.4157110089893623, 0, 0], [747, "SRP-dependent cotranslational protein targeting to membrane (GO:0006614)", 0.34619411785401744, 2.3942249607345656, 2.5396875993674386, ["RPL36A"], 0.4157110089893623, 0, 0], [748, "cellular component assembly (GO:0022607)", 0.3477150740561105, 1.6490683229813665, 1.7420294166032309, ["FBLIM1", "ADD2"], 0.41697917303252824, 0, 0], [749, "positive regulation of supramolecular fiber organization (GO:1902905)", 0.3492808907923712, 2.3675029868578257, 2.490326285607444, ["CX3CL1"], 0.41829767562183834, 0, 0], [750, "negative regulation of mitotic cell cycle phase transition (GO:1901991)", 0.3523532446269213, 2.3413683091102446, 2.4423306175433335, ["CCL2"], 0.4202936973807824, 0, 0], [751, "regulation of endothelial cell proliferation (GO:0001936)", 0.3523532446269213, 2.3413683091102446, 2.4423306175433335, ["PPP1R16B"], 0.4202936973807824, 0, 0], [752, "positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100)", 0.3523532446269213, 2.3413683091102446, 2.4423306175433335, ["FOXD1"], 0.4202936973807824, 0, 0], [753, "regulation of heart contraction (GO:0008016)", 0.35541124598652435, 2.315801776531089, 2.395649974707396, ["HCN4"], 0.42281682712189966, 0, 0], [754, "cytoplasmic translation (GO:0002181)", 0.35541124598652435, 2.315801776531089, 2.395649974707396, ["RPL36A"], 0.42281682712189966, 0, 0], [755, "protein-containing complex assembly (GO:0065003)", 0.3579326206989374, 1.6112387202625102, 1.6554036124495808, ["CX3CL1", "ADD2"], 0.42418746730434603, 0, 0], [756, "cotranslational protein targeting to membrane (GO:0006613)", 0.35845496122262466, 2.290785061856862, 2.350236106834253, ["RPL36A"], 0.42418746730434603, 0, 0], [757, "hemopoiesis (GO:0030097)", 0.35845496122262466, 2.290785061856862, 2.350236106834253, ["IFI16"], 0.42418746730434603, 0, 0], [758, "interleukin-1-mediated signaling pathway (GO:0070498)", 0.35845496122262466, 2.290785061856862, 2.350236106834253, ["IL1A"], 0.42418746730434603, 0, 0], [759, "central nervous system development (GO:0007417)", 0.3596302073259856, 1.6050997057862046, 1.6415017256383941, ["ADORA2A", "DCLK1"], 0.4250175177488921, 0, 0], [760, "positive regulation of cell migration (GO:0030335)", 0.36132620730176906, 1.5990066764370623, 1.6277473940682363, ["CCL5", "HBEGF"], 0.4264600104601143, 0, 0], [761, "cellular transition metal ion homeostasis (GO:0046916)", 0.364499797099579, 2.242331635540464, 2.2630267514478994, ["MT2A"], 0.4296403653065997, 0, 0], [762, "inorganic cation transmembrane transport (GO:0098662)", 0.36978162882081655, 1.5692135549872124, 1.561120555692123, ["HCN4", "SLC6A4"], 0.4349842725862267, 0, 0], [763, "negative regulation of neuron death (GO:1901215)", 0.3704882767624049, 2.195876288659794, 2.180359077073003, ["CCL2"], 0.4349842725862267, 0, 0], [764, "regulation of neuron apoptotic process (GO:0043523)", 0.3704882767624049, 2.195876288659794, 2.180359077073003, ["CCL2"], 0.4349842725862267, 0, 0], [765, "negative regulation of nucleic acid-templated transcription (GO:1903507)", 0.37279508900562247, 1.3905508807894924, 1.3720932222421098, ["JUN", "FOXD1", "IFI16"], 0.4371205161281613, 0, 0], [766, "positive regulation of translation (GO:0045727)", 0.3764209201158763, 2.1512979254914737, 2.101919815261755, ["CCL5"], 0.4403313063369234, 0, 0], [767, "plasma membrane bounded cell projection assembly (GO:0120031)", 0.3765151749837461, 1.5461562696912414, 1.510280693132307, ["ARHGEF4", "FHDC1"], 0.4403313063369234, 0, 0], [768, "epithelial cell differentiation (GO:0030855)", 0.37936646429876497, 2.129677419354839, 2.0641954116468115, ["PCK2"], 0.4425119876150744, 0, 0], [769, "positive regulation of cell cycle process (GO:0090068)", 0.37936646429876497, 2.129677419354839, 2.0641954116468115, ["IL1A"], 0.4425119876150744, 0, 0], [770, "regulation of cell death (GO:0010941)", 0.3822982421487303, 2.1084850420525925, 2.027422724538319, ["CCL5"], 0.44362422148436104, 0, 0], [771, "calcium-mediated signaling (GO:0019722)", 0.3822982421487303, 2.1084850420525925, 2.027422724538319, ["CCL20"], 0.44362422148436104, 0, 0], [772, "cell junction assembly (GO:0034329)", 0.3822982421487303, 2.1084850420525925, 2.027422724538319, ["FBLIM1"], 0.44362422148436104, 0, 0], [773, "positive regulation of vasculature development (GO:1904018)", 0.3822982421487303, 2.1084850420525925, 2.027422724538319, ["IL1A"], 0.44362422148436104, 0, 0], [774, "protein targeting to ER (GO:0045047)", 0.38521631738428525, 2.087708201560194, 1.9915697381425963, ["RPL36A"], 0.44643286394535386, 0, 0], [775, "regulation of insulin secretion (GO:0050796)", 0.3881207532938546, 2.0673347948637644, 1.956605796187279, ["CCL5"], 0.4492184718768872, 0, 0], [776, "positive regulation of cellular metabolic process (GO:0031325)", 0.3910116129734624, 2.0473531844499586, 1.922501530920028, ["CCL5"], 0.4519812072644275, 0, 0], [777, "proteolysis (GO:0006508)", 0.3915583813229732, 1.496643783371472, 1.4032841207483167, ["CASP4", "TRABD2A"], 0.45203071820683005, 0, 0], [778, "protein processing (GO:0016485)", 0.3938889592186841, 2.027752176139273, 1.889228798205254, ["CASP4"], 0.4523923129566705, 0, 0], [779, "cellular response to peptide hormone stimulus (GO:0071375)", 0.3938889592186841, 2.027752176139273, 1.889228798205254, ["PCK2"], 0.4523923129566705, 0, 0], [780, "small GTPase mediated signal transduction (GO:0007264)", 0.3938889592186841, 2.027752176139273, 1.889228798205254, ["JUN"], 0.4523923129566705, 0, 0], [781, "protein localization to nucleus (GO:0034504)", 0.3938889592186841, 2.027752176139273, 1.889228798205254, ["GBP2"], 0.4523923129566705, 0, 0], [782, "neutrophil degranulation (GO:0043312)", 0.3945017241336464, 1.339923674651708, 1.2463055768617028, ["C3AR1", "CXCL1", "TLR2"], 0.45251668356506497, 0, 0], [783, "regulation of gene expression (GO:0010468)", 0.3968611672139237, 1.1967084639498433, 1.1059605822442657, ["PARP10", "IL1A", "FOXD1", "IFI16", "STC2", "TLR2"], 0.4546417202948781, 0, 0], [784, "negative regulation of apoptotic process (GO:0043066)", 0.39958417579836153, 1.3285303907710546, 1.2187018901594242, ["CCL2", "CX3CL1", "IFIT3"], 0.45603589676544143, 0, 0], [785, "neutrophil activation involved in immune response (GO:0002283)", 0.39958417579836153, 1.3285303907710546, 1.2187018901594242, ["C3AR1", "CXCL1", "TLR2"], 0.45603589676544143, 0, 0], [786, "negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)", 0.3996033610453032, 1.9896492814792484, 1.8250711061513005, ["BMPER"], 0.45603589676544143, 0, 0], [787, "modulation of chemical synaptic transmission (GO:0050804)", 0.4024405407353385, 1.971127041019514, 1.7941354399563882, ["GRID1"], 0.45869017158780007, 0, 0], [788, "neutrophil mediated immunity (GO:0002446)", 0.4033888328940802, 1.3201087572221593, 1.1984664596436867, ["C3AR1", "CXCL1", "TLR2"], 0.4591875420126776, 0, 0], [789, "regulation of protein serine/threonine kinase activity (GO:0071900)", 0.4080751659876367, 1.9350928641251222, 1.7344312639186088, ["HERC5"], 0.4633461061910255, 0, 0], [790, "Fc-epsilon receptor signaling pathway (GO:0038095)", 0.4080751659876367, 1.9350928641251222, 1.7344312639186088, ["JUN"], 0.4633461061910255, 0, 0], [791, "protein-containing complex subunit organization (GO:0043933)", 0.4108727339662438, 1.917562724014337, 1.705617895170707, ["ADD2"], 0.46534449793904126, 0, 0], [792, "Fc receptor signaling pathway (GO:0038093)", 0.4108727339662438, 1.917562724014337, 1.705617895170707, ["JUN"], 0.46534449793904126, 0, 0], [793, "protein phosphorylation (GO:0006468)", 0.4135021555643219, 1.2981521521075274, 1.1463884963164583, ["CCL2", "DCLK1", "TLR2"], 0.46731804319534526, 0, 0], [794, "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)", 0.4136572199521785, 1.9003456221198156, 1.6774685632988202, ["RPL36A"], 0.46731804319534526, 0, 0], [795, "cellular response to transforming growth factor beta stimulus (GO:0071560)", 0.4164286844807403, 1.883433247692454, 1.6499629711192532, ["JUN"], 0.4692669974613367, 0, 0], [796, "positive regulation of cellular component organization (GO:0051130)", 0.4164286844807403, 1.883433247692454, 1.6499629711192532, ["TRABD2A"], 0.4692669974613367, 0, 0], [797, "calcium ion transport (GO:0006816)", 0.41918718785650966, 1.8668175815883796, 1.6230816026792019, ["CCL5"], 0.4717828199589575, 0, 0], [798, "ion transport (GO:0006811)", 0.4219327899590496, 1.8504908835904628, 1.596805687778204, ["HCN4"], 0.4736842460491458, 0, 0], [799, "tumor necrosis factor-mediated signaling pathway (GO:0033209)", 0.4219327899590496, 1.8504908835904628, 1.596805687778204, ["TNFRSF9"], 0.4736842460491458, 0, 0], [800, "positive regulation of cell projection organization (GO:0031346)", 0.42466555054147775, 1.8344456803856137, 1.5711171662632402, ["CX3CL1"], 0.47615624854463195, 0, 0], [801, "adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189)", 0.4273855290171557, 1.8186747541586252, 1.5459986564782813, ["ADORA2A"], 0.4780109969181903, 0, 0], [802, "positive regulation of protein-containing complex assembly (GO:0031334)", 0.4273855290171557, 1.8186747541586252, 1.5459986564782813, ["TRABD2A"], 0.4780109969181903, 0, 0], [803, "positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)", 0.43009278453070354, 1.8031711317659924, 1.5214334241800327, ["CASP4"], 0.48043988508597896, 0, 0], [804, "cytoskeleton organization (GO:0007010)", 0.43278737594051114, 1.7879280744555888, 1.497405353482253, ["CCL2"], 0.4828486022619882, 0, 0], [805, "protein polyubiquitination (GO:0000209)", 0.4356796426212086, 1.3652452619843924, 1.1343113914539935, ["HERC5", "UBE2L6"], 0.4854716017779182, 0, 0], [806, "potassium ion transport (GO:0006813)", 0.43813880056248883, 1.758197813916289, 1.450899160540218, ["HCN4"], 0.48760608449696335, 0, 0], [807, "regulation of anatomical structure morphogenesis (GO:0022603)", 0.4407957502910964, 1.7436982196368764, 1.4283916561603158, ["BMPER"], 0.48934874753850677, 0, 0], [808, "positive regulation of epithelial cell proliferation (GO:0050679)", 0.4407957502910964, 1.7436982196368764, 1.4283916561603158, ["PPP1R16B"], 0.48934874753850677, 0, 0], [809, "cellular response to oxidative stress (GO:0034599)", 0.4460724133722961, 1.7154006243496358, 1.384798286431403, ["JUN"], 0.49398389480857974, 0, 0], [810, "regulation of phosphorylation (GO:0042325)", 0.4460724133722961, 1.7154006243496358, 1.384798286431403, ["CCL5"], 0.49398389480857974, 0, 0], [811, "negative regulation of gene expression (GO:0010629)", 0.4484299433554305, 1.3305706521739131, 1.0671214043289576, ["PARP10", "STC2"], 0.49505158758233153, 0, 0], [812, "negative regulation of growth (GO:0045926)", 0.44869224158799953, 1.7015913978494623, 1.3636860719007413, ["MT2A"], 0.49505158758233153, 0, 0], [813, "synapse organization (GO:0050808)", 0.44869224158799953, 1.7015913978494623, 1.3636860719007413, ["CX3CL1"], 0.49505158758233153, 0, 0], [814, "plasma membrane bounded cell projection organization (GO:0120036)", 0.45389517642532135, 1.6746253492506984, 1.3227681366845945, ["NRTN"], 0.5001768713188123, 0, 0], [815, "cellular response to insulin stimulus (GO:0032869)", 0.45647839632867754, 1.6614583333333333, 1.3029387269935697, ["PCK2"], 0.5017905900818919, 0, 0], [816, "muscle contraction (GO:0006936)", 0.45647839632867754, 1.6614583333333333, 1.3029387269935697, ["HCN4"], 0.5017905900818919, 0, 0], [817, "Golgi organization (GO:0007030)", 0.4590495262603869, 1.6484954571976327, 1.2835139049737554, ["FHDC1"], 0.5033831602146297, 0, 0], [818, "protein glycosylation (GO:0006486)", 0.4590495262603869, 1.6484954571976327, 1.2835139049737554, ["GFPT2"], 0.5033831602146297, 0, 0], [819, "regulation of cell motility (GO:2000145)", 0.46669093472805845, 1.6107852720755946, 1.2275602076257284, ["HBEGF"], 0.5105143517695957, 0, 0], [820, "transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)", 0.46669093472805845, 1.6107852720755946, 1.2275602076257284, ["JUN"], 0.5105143517695957, 0, 0], [821, "positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)", 0.46921426205352185, 1.5985932573368906, 1.2096487495928274, ["CCL5"], 0.5126494434372827, 0, 0], [822, "negative regulation of inflammatory response to antigenic stimulus (GO:0002862)", 0.4742255335075623, 1.5747510951812027, 1.1748781106619628, ["ADORA2A"], 0.5168654964231876, 0, 0], [823, "organic substance transport (GO:0071702)", 0.4742255335075623, 1.5747510951812027, 1.1748781106619628, ["SLC6A4"], 0.5168654964231876, 0, 0], [824, "negative regulation of cellular macromolecule biosynthetic process (GO:2000113)", 0.4765670297282597, 1.1733597285067874, 0.8696319192519986, ["JUN", "FOXD1", "IFI16"], 0.5183176816346182, 0, 0], [825, "regulation of inflammatory response to antigenic stimulus (GO:0002861)", 0.4767135867876924, 1.5630929791271346, 1.1580008889040445, ["ADORA2A"], 0.5183176816346182, 0, 0], [826, "potassium ion transmembrane transport (GO:0071805)", 0.48165479960454133, 1.5402836216300453, 1.1252197049860213, ["HCN4"], 0.5230561201516629, 0, 0], [827, "post-translational protein modification (GO:0043687)", 0.4841781784449415, 1.239890987450881, 0.8992957883304029, ["IGFBP1", "STC2"], 0.5251606119287938, 0, 0], [828, "regulation of small GTPase mediated signal transduction (GO:0051056)", 0.4865498458007512, 1.5181259600614438, 1.0936821172345188, ["ARHGEF4"], 0.5270956662841472, 0, 0], [829, "Ras protein signal transduction (GO:0007265)", 0.48898018996960635, 1.5072828490810646, 1.0783603452195967, ["JUN"], 0.5278862749195216, 0, 0], [830, "protein localization to organelle (GO:0033365)", 0.48898018996960635, 1.5072828490810646, 1.0783603452195967, ["GBP2"], 0.5278862749195216, 0, 0], [831, "receptor-mediated endocytosis (GO:0006898)", 0.4913991522383506, 1.4965924579736483, 1.0633267624911829, ["SAA1"], 0.5278862749195216, 0, 0], [832, "negative regulation of DNA-binding transcription factor activity (GO:0043433)", 0.4913991522383506, 1.4965924579736483, 1.0633267624911829, ["PARP10"], 0.5278862749195216, 0, 0], [833, "neuron development (GO:0048666)", 0.4913991522383506, 1.4965924579736483, 1.0633267624911829, ["NRTN"], 0.5278862749195216, 0, 0], [834, "nitrogen compound transport (GO:0071705)", 0.4913991522383506, 1.4965924579736483, 1.0633267624911829, ["SLC6A4"], 0.5278862749195216, 0, 0], [835, "monocarboxylic acid metabolic process (GO:0032787)", 0.4913991522383506, 1.4965924579736483, 1.0633267624911829, ["KYNU"], 0.5278862749195216, 0, 0], [836, "supramolecular fiber organization (GO:0097435)", 0.49327119346404574, 1.2182010713840787, 0.860898029025125, ["SAA1", "UBE2L6"], 0.529263469542164, 0, 0], [837, "brain development (GO:0007420)", 0.5080175934086562, 1.4257775853359314, 0.9655924702858366, ["SLC6A4"], 0.5444346251942229, 0, 0], [838, "positive regulation of Wnt signaling pathway (GO:0030177)", 0.5149742516646719, 1.3974250141482738, 0.927384867440544, ["TLR2"], 0.5512313887150486, 0, 0], [839, "positive regulation of protein kinase activity (GO:0045860)", 0.5172714405902054, 1.388221238316115, 0.9150981043281485, ["CCL5"], 0.553030372120875, 0, 0], [840, "cellular response to starvation (GO:0009267)", 0.5263530458751823, 1.3525785905074994, 0.8680620828584756, ["IFI16"], 0.561401524554148, 0, 0], [841, "T cell receptor signaling pathway (GO:0050852)", 0.5263530458751823, 1.3525785905074994, 0.8680620828584756, ["THEMIS2"], 0.561401524554148, 0, 0], [842, "peptide biosynthetic process (GO:0043043)", 0.5352655814613116, 1.3187070059440327, 0.8241816472793192, ["RPL36A"], 0.5695530564303637, 0, 0], [843, "rRNA metabolic process (GO:0016072)", 0.5352655814613116, 1.3187070059440327, 0.8241816472793192, ["RPL36A"], 0.5695530564303637, 0, 0], [844, "negative regulation of programmed cell death (GO:0043069)", 0.5372103172586166, 1.1200527704485488, 0.6959622717080048, ["CX3CL1", "IFIT3"], 0.5709450883660889, 0, 0], [845, "negative regulation of canonical Wnt signaling pathway (GO:0090090)", 0.5418409067477014, 1.2943876212955678, 0.7931785363803898, ["IGFBP1"], 0.573826792624189, 0, 0], [846, "adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188)", 0.5418409067477014, 1.2943876212955678, 0.7931785363803898, ["ADORA2A"], 0.573826792624189, 0, 0], [847, "regulation of neuron projection development (GO:0010975)", 0.5418409067477014, 1.2943876212955678, 0.7931785363803898, ["CX3CL1"], 0.573826792624189, 0, 0], [848, "regulation of MAPK cascade (GO:0043408)", 0.5440121615938746, 1.286477680026067, 0.7831866117878795, ["CX3CL1"], 0.5754468265916338, 0, 0], [849, "nuclear-transcribed mRNA catabolic process (GO:0000956)", 0.5547166646644444, 1.2483238456672991, 0.7356345080611539, ["RPL36A"], 0.5853892331811842, 0, 0], [850, "positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)", 0.5547166646644444, 1.2483238456672991, 0.7356345080611539, ["CX3CL1"], 0.5853892331811842, 0, 0], [851, "rRNA processing (GO:0006364)", 0.5589285117392199, 1.2336834208552139, 0.7176752210199345, ["RPL36A"], 0.5891408637251235, 0, 0], [852, "cation transport (GO:0006812)", 0.5610196301714814, 1.2264901485486979, 0.7089105487225444, ["HCN4"], 0.590650948666454, 0, 0], [853, "mitochondrion organization (GO:0007005)", 0.5631009394771997, 1.2193795575330615, 0.7002852636897744, ["IFIT2"], 0.592059133450049, 0, 0], [854, "phosphorylation (GO:0016310)", 0.5636772574875606, 1.0655451168887917, 0.6108487037359085, ["CCL2", "DCLK1"], 0.592059133450049, 0, 0], [855, "positive regulation of developmental process (GO:0051094)", 0.5672343129241839, 1.2054007820136852, 0.6834415229378875, ["FOXD1"], 0.5950984546116876, 0, 0], [856, "protein stabilization (GO:0050821)", 0.5713289936848839, 1.1917361362812613, 0.6671220482050944, ["STX12"], 0.5986940506253983, 0, 0], [857, "positive regulation of cellular biosynthetic process (GO:0031328)", 0.5733619364271537, 1.185018321619511, 0.6591523514975058, ["CCL5"], 0.6001232870188529, 0, 0], [858, "antigen receptor-mediated signaling pathway (GO:0050851)", 0.5833844469790498, 1.152524544179523, 0.6211057126348188, ["THEMIS2"], 0.6099019218417339, 0, 0], [859, "organelle assembly (GO:0070925)", 0.5968491465161645, 1.001284818583616, 0.5167539665804248, ["STX12", "FHDC1"], 0.622240512960439, 0, 0], [860, "ribosome biogenesis (GO:0042254)", 0.5970257237871581, 1.1098913471823453, 0.5724764940992287, ["RPL36A"], 0.622240512960439, 0, 0], [861, "regulation of transcription by RNA polymerase II (GO:0006357)", 0.5972676495640334, 0.9600789313904068, 0.49481502460050514, ["JUN", "FOXD1", "ZBTB25", "IFI16", "IRF7", "ZNF239", "FHL5", "CX3CL1", "TLR2", "IRF2BPL"], 0.622240512960439, 0, 0], [862, "negative regulation of intracellular signal transduction (GO:1902532)", 0.6083658592709782, 1.0757600567654604, 0.5346299805772539, ["NMI"], 0.6330674892877812, 0, 0], [863, "regulation of intracellular signal transduction (GO:1902531)", 0.6120986074797473, 0.9730634682658671, 0.4776397693434244, ["PPP1R16B", "ARHGEF4"], 0.6362137322240247, 0, 0], [864, "modification-dependent protein catabolic process (GO:0019941)", 0.6139169430315261, 1.059462365591398, 0.5169070603564077, ["UBE2L6"], 0.6366283212708427, 0, 0], [865, "ncRNA processing (GO:0034470)", 0.6139169430315261, 1.059462365591398, 0.5169070603564077, ["RPL36A"], 0.6366283212708427, 0, 0], [866, "phosphate-containing compound metabolic process (GO:0006796)", 0.6336129765990864, 1.0036691637364317, 0.457991259582563, ["GFPT2"], 0.6562942725281531, 0, 0], [867, "negative regulation of multicellular organismal process (GO:0051241)", 0.637085719846623, 0.9941440759250846, 0.44821091481305636, ["SLC6A4"], 0.6583708418230654, 0, 0], [868, "translation (GO:0006412)", 0.637085719846623, 0.9941440759250846, 0.44821091481305636, ["RPL36A"], 0.6583708418230654, 0, 0], [869, "extracellular structure organization (GO:0043062)", 0.6405258939677524, 0.9847961990497625, 0.43869295842203554, ["ICAM1"], 0.6611642426801771, 0, 0], [870, "external encapsulating structure organization (GO:0045229)", 0.6422338620760967, 0.9801871764237355, 0.4340295973057075, ["ICAM1"], 0.6621652577956997, 0, 0], [871, "transcription, DNA-templated (GO:0006351)", 0.6489858155701543, 0.9621700879765396, 0.4159888670313223, ["HSF2BP"], 0.6683585264826963, 0, 0], [872, "regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122)", 0.6539669014612337, 0.9490814407637784, 0.4030735005176567, ["CX3CL1"], 0.672715952535237, 0, 0], [873, "cilium organization (GO:0044782)", 0.6604997168328015, 0.9321680640424423, 0.3866247060464274, ["FHDC1"], 0.6786577846495108, 0, 0], [874, "regulation of autophagy (GO:0010506)", 0.6653191108535186, 0.9198690977092099, 0.37483606730510444, ["IFI16"], 0.6828275085075586, 0, 0], [875, "membrane organization (GO:0061024)", 0.682418153033612, 0.877392584660688, 0.3352628331733753, ["HBEGF"], 0.6995760951670285, 0, 0], [876, "positive regulation of nucleic acid-templated transcription (GO:1903508)", 0.6965795426176677, 0.828435978474417, 0.2995403214259702, ["JUN", "IRF7"], 0.7132783672694611, 0, 0], [877, "regulation of canonical Wnt signaling pathway (GO:0060828)", 0.6986524120092831, 0.8386243386243386, 0.30073230224620795, ["IGFBP1"], 0.7137713138636981, 0, 0], [878, "positive regulation of phosphorylation (GO:0042327)", 0.6986524120092831, 0.8386243386243386, 0.30073230224620795, ["CCL5"], 0.7137713138636981, 0, 0], [879, "positive regulation of cell differentiation (GO:0045597)", 0.7057575309544657, 0.8220994937450316, 0.28648814267775824, ["IFITM1"], 0.7202099036019974, 0, 0], [880, "protein ubiquitination (GO:0016567)", 0.7107603960931563, 0.8056779449663314, 0.27507448471124046, ["HERC5", "UBE2L6"], 0.7244909946540469, 0, 0], [881, "regulation of protein phosphorylation (GO:0001932)", 0.7167824869768546, 0.7969567863664029, 0.26537294193225086, ["BMPER"], 0.7298001030854013, 0, 0], [882, "regulation of cell cycle (GO:0051726)", 0.7546051909206433, 0.7148168398031711, 0.20126425290070094, ["JUN"], 0.7674386125349398, 0, 0], [883, "extracellular matrix organization (GO:0030198)", 0.7592548381757995, 0.7051102240443053, 0.19419990861506237, ["ICAM1"], 0.7712928537301158, 0, 0], [884, "chemical synaptic transmission (GO:0007268)", 0.7660663515946587, 0.6910276749515247, 0.1841495410502552, ["GRID1"], 0.7773320332357566, 0, 0], [885, "cellular macromolecule biosynthetic process (GO:0034645)", 0.7748525957984838, 0.6730907966608265, 0.17169366071764278, ["RPL36A"], 0.7844726618862753, 0, 0], [886, "cilium assembly (GO:0060271)", 0.7748525957984838, 0.6730907966608265, 0.17169366071764278, ["FHDC1"], 0.7844726618862753, 0, 0], [887, "transcription by RNA polymerase II (GO:0006366)", 0.7812272678962782, 0.660228536758014, 0.16300327904717365, ["HSF2BP"], 0.7900347906459544, 0, 0], [888, "cellular protein localization (GO:0034613)", 0.7904559098952111, 0.6418174665617624, 0.15092042416145118, ["STX12"], 0.7984672873603652, 0, 0], [889, "intracellular protein transport (GO:0006886)", 0.7973665130842648, 0.6281816722837426, 0.14224598557314297, ["STX12"], 0.8045419147768116, 0, 0], [890, "cellular response to DNA damage stimulus (GO:0006974)", 0.8105183151507495, 0.6025510675663185, 0.12658473612267165, ["IRF7"], 0.8168931783036205, 0, 0], [891, "ubiquitin-dependent protein catabolic process (GO:0006511)", 0.8141183293587055, 0.5956014499375553, 0.12248517360273081, ["UBE2L6"], 0.8196006076708854, 0, 0], [892, "gene expression (GO:0010467)", 0.8158928755273476, 0.5921853702862335, 0.12049326757747801, ["RPL36A"], 0.8204662660852363, 0, 0], [893, "protein transport (GO:0015031)", 0.8270257648139828, 0.57088592800374, 0.10842232998004626, ["STX12"], 0.830730247523116, 0, 0], [894, "positive regulation of protein phosphorylation (GO:0001934)", 0.828678345694389, 0.567741935483871, 0.10669188238072377, ["CX3CL1"], 0.8314591455121555, 0, 0], [895, "protein modification by small protein conjugation (GO:0032446)", 0.8572693253533527, 0.5138625342610162, 0.07913644609923648, ["HERC5"], 0.8591850109966005, 0, 0], [896, "organelle organization (GO:0006996)", 0.8646261488974768, 0.5000898195909359, 0.07274209662425941, ["CCL2"], 0.865591133438657, 0, 0], [897, "regulation of transcription, DNA-templated (GO:0006355)", 0.9143447108858688, 0.6355134904608492, 0.05690872896291105, ["JUN", "FOXD1", "ZBTB25", "IFI16", "IRF7", "ZNF239", "IRF2BPL"], 0.9143447108858688, 0, 0]]